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ABSTRACT. 
The major urinary proteins (MtJPs) of inbred mouse strains are coded 
for by a family of about 35 genes which are clustered on chromosome 
4 (Bishop et al., 1982). Four groups of Mup genes which exhibit 
tissue specific expression and hormonal dependency have been 
identified (Knopf et al., 1984; Kuhn et al., 1984). The complete 
sequence of a group 1 gene (B56) and a group 2 gene (3S2) are known 
together with 700 base pairs (bp) of 5' flanking sequence (Clark et 
al., 1985b). The sequence of the group 1 gene is consistent with it 
being active. The group 2 gene has several lesions and cannot be 
translated to give a protein with the molecular weight of MU? 
(Ghazal et al., 1985). This makes it a pseudogene in the context 
of a group 1 gene. Consistent with this is the observation that no 
BS2 transcripts are detected in mouse liver RNA. It does not 
necessarily follow from these observations that the promoter 
sequences of the group 2 BS2 gene is defective in its capacity to 
initiate transcription from the BS2 CAP site. This was investigated 
by implementing standard reverse genetic techniques. Constructs were 
made containing the SV40 enhancer and early promoter region and 
approximately 2.2 kilobases (kb) of 5' flanking sequence from BS6 or 
BS2 linked to the Herpes simplex virus thymidine kinase type 1 gene 
(HSVtk). After trarisfection of cultured cells with the recombinant 
plasmids, two assays were used to measure gene expression. Transient 
levels of tk specific mRNA and thymidine kinase enzyme (TK) 
activity were measured as well as the rate of transformation from a 
TK to a TK+  phenotype in selective growth medium. Transient 
expression was only detectable with constructs containing the BS6 
promoter. The transformation efficiency of BS6 constructs was twice 
that of the BS2 constructs. Individual clones stably transfected 
with BS6 and BS2 constructs were isolated. Among the clones that 
carried the BS2 construct the size of the tk mRNA was very 
heterogeneous. Primer extension and Si nuclease mapping showed that 
these transcripts were not initiated at the BS2 CAP site. The clones 
showed a variety of rearrangements which were consistent with the 
activation of the tk coding sequences by different cellular 
promoters. The BS2 promoter had been deleted in all cases. It is 
concluded that the promoter region of the BS2 pseudogene is not 
capable of directing accurate transcription in BHKtk 
fibroblast cells. To analyse the effects of the Mup coding regions 
in a more appropriate environment, the sequences of Mup and 
thymidine kinase were microinjected into mouse embryos to create 
lines of transgenic animals. One line expressed HSV thymidine kinase 
in the liver. The expression was not sexually dimorphic. The size of 
tk specific transcripts were consistent with the initiation of 
transcription from the BS2 CAP site. In addition, this line and 
other G males expressed the reporter sequences at high levels 
in the testis. This tissue does not exhibit any endogenous Mup 
expression. It is suggested that 2.2 kb of a group 2 Mup gene 
promoter region is able to direct the synthesis of an HSVtk 
reporter gene to the liver and testis when removed away from an 
endogenous silencing element. 
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CHAPTER 1: THE MOUSE URINARY PROTEIN GENES. 
Introduction. 
The major urinary proteins (MtJPs) of inbred strains of mice are 
coded for by a family of about 35 genes, located on chromosome 4. 
They are defined as sequences that hybridise with Mup specific 
probes (Hastie et al., 1979; Bishop et al., 1982; Clark et 
al., 1982). The proteins are acidic and have a molecular weight of 
about 19500 Daltons. They are synthesised in the liver, 
submaxillary, lachrymal, sublingual, parotid and mammary glands. 
Recently expression has been observed in the sebaceous glands of the 
skin (Held et al., 1989). The rat gene homologue to Mup, a2u-
globulin, has a similar distribution of tissue specific expression 
except that it is expressed at high levels in the preputial gland, 
whereas Mup is not (Maclnnes et al., 1986). In addition the rat 
genes are only expressed in the male liver whereas Mup genes are 
expressed in both male and female liver. In each tissue MU? is 
synthesised as a precursor, secreted into the blood and excreted in 
the urine. No biological function has been assigned to the Mup 
gene product. However they clearly belong to a protein superfamily, 
other members of which bind small hydrophobic substances (Sawyer, 
1987). These include -lactoglobulin which binds retinol in several 
species and human urinary protein (HC) which may mediate the 
excretion of retinol derived metabolites (Unterman et al., 1981; 
Pervaiz & Brew, 1985; Ali & Clark, 1988). It has been suggested that 
MUP5 may be involved in binding pheromones thereby facilitating 
secretion and excretion of these molecules. Held et al., (1989) 
show that a Mup/8V40 T-antigen transgene was expressed in the 
sebaceous glands of transgenic mice. This is consistent with the 
finding of Mup mRNA in the skin of transgenic animals. This lends 
support to the theory that MUP5 may have a role in the transport and 
excretion of small molecules. Although a definite function for MUPs 
is not established, this multigene family provides an interesting 
model of developmental and tissue specific multihormonal control of 
gene expression. 
Mup gene expression is detected in the liver of mice between 2 and 
4 weeks of age (Barth et al., 1982). This time period corresponds 
to the onset of sexual maturity and an increase in the circulation 
of testosterone. Consistent with this observation, Held et al., 
(1989) found expression of aMup/SV4O T-antigen transgene in the 
liver of mice at around 3 weeks. 
Mup genes can be divided into four groups. 
Analysis of the structure of the specified protein and comparison of 
restriction sites and nucleotide sequence show that there are four 
main phylogenetic groups of Mup genes (Al Shawi et al., 1989, in 
press): 
Group 1 genes. 
Group 1 genes are expressed in the liver and are detectable at low 
levels in the prelactational mammary gland (Clissold & Bishop, 1982; 
Shahan et al., 1987a). The liver synthesises a great deal of Mup 
mRNA. This constitutes about 5-10% of total mRNA in the adult male 
liver and about 1-2% in the adult female liver (Derman, 1981). It 
has been calculated that approximately 90% of the Mup mRNA in the 
male mouse liver corresponds to group 1 transcripts (Clark et al., 
1984a; Kuhn et al., 1984). To date only four group 1 genes are 
known to be expressed in BALB/c mice; cLivl and cLiv6 (Shahan et 
al., 1987a); p1057 (Kuhn et al., 1984) and pMUP(11) (Clark et 
al., 1985a). Clark et al., (1982) describe the sequences of four 
group 1 genes isolated as geriomic clones from BALB/c DNA. They are 
named BS6, BS5, BS1 and BL1. These sequences show a nucleotide 
homology of approximately 98%. Sequence analysis has shown that 
cLivi is identical to BS1 and cLiv6 is identical to BL1. The 
pMUP(11) clone appears to be the same as the BS6 genomic clone (J. 
Bishop, personal communication). 
Shahan et al., (1987a) isolated the cDNA clones cLivi and cLiv6 
from male and female liver libraries respectively. Four out of five 
clones isolated from the male liver library were identical to cLivi 
(BS1) and eight out of nine from the female library were identical 
in sequence to cLiv6 (BL1). This work proposes that these 
transcripts represent the major Mup mRNA species in the liver of 
male and female mice. There is evidence that each of these genes is 
present in the BALB/c genome in a single copy (Al Shawi et al., 
1989, in press). Hybridisation with oligonucleotide probes was used 
to investigate the RNA extracted from the livers of both sexes 
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(Shahan et al., 1987b). These probes did not discriminate between 
cLivi and cLiv6. The results are inconclusive in determining whether 
each gene is expressed exclusively in one sex or the other. 
Using gene specific probes McIntosh & Bishop (1989) show that the 
group 1 genes BS1 and BL1 are expressed at different levels in male 
and female mice. Probing of mPNA transcripts with group 1 gene 
specific probes has shown that BL1 is the most abundantly 
expressed Mup gene in male and female livers. This is in 
contradiction to the work of Shahan and colleagues (1987). The BL1 
RNA constitutes approximately 60% of male and 75% of female total 
Mup RNA. BS1 RNA was also detected. In the male this occurred at 
levels which were one third that of BL1. In the female, BS1 
transcripts are detectable but at a much lower level compared to 
BL1. The levels of both RNA5 in the female liver are raised to male-
like levels when testosterone is administered continuously by a 
subcutaneous pellet. Neither RNA was detected in the prelactational 
mammary gland. 
The group 1 gene BS6 (pMUP(11)) is also expressed at different 
levels in male and female mice. Al Shawi et al., (1988) analysed 
the expression of a Mup/tk transgene containing 2.2 kb of BS6 5' 
flanking region linked to the coding region of a Herpes simplex 
virus type 1 thymidine kinase gene (HSVtk). In three out of five 
lines the levels of HSVTK in the liver had a similar male to female 
ratio of 10. 
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Group 1 genes are expressed in the mammary gland. 
Shahan et al., (1987b) isolated 5 cDNA clones from a 
prelactational mammary gland cDNA library. Two of these clones were 
sequenced and found to be identical to the cLiv6 clones isolated 
from the female liver library. It has been proposed that the BL1 
gene is the most abundantly expressed group 1 gene in the mammary 
gland. In contrast McIntosh & Bishop (1989) failed to detect any 
BL1- or BS1-specific transcripts when RNA from this tissue was 
hybridised with the two gene-specific probes. 
Group 2 genes. 
Group 2 genes are pseudogenes in the context of group 1 genes. They 
include the genes BS2, BS102, BS109 and BL25 (Clark et al., 1982). 
They are distinguishable from the group 1 genes on the basis of 
nucleic acid hybridisation experiments (Bishop et al., 1982). 
Sequence comparisons of the first exon of four group 2 genes show a 
nucleotide homology of 98% and the presence of a nonsense mutation 
(TGA) at amino acid 7 (Ghazal et al., 1985). The sequence cannot 
be translated to give a protein with the molecular weight of MU?. 
Other lesions are also present. BL25 contains a stop codon in place 
of amino acid 2 and BS2 contains a second stop codon and a 
frameshift mutation (Clark et al., 1985b). It has been suggested 
that although the nonsense mutation does not allow the genes to 
encode a full length MU? protein, a smaller peptide could be a 
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viable translation product (Clark etal., 1984a). 
Shahan et al., (1987b) constructed an oligonucleotide probe 
derived from a sequence conserved in the four group 2 genes and 
which spans the nonsense mutation. No complementary RNA was detected 
when this was hybridised to RNA from several Mup expressing 
tissues. This result was confirmed with a group 2 gene specific 
oligonucleotide probe on different RNA samples (McIntosh & Bishop, 
1989). Thus it appears that the group 2 genes are not transcribed 
into stable RNA. The sequence of a group 1 gene (BS6) and a group 2 
gene (BS2) have been published (Clark et al., 1985b). They show a 
13% divergence over the full length of the gene. 
Group 3 genes. 
These genes are also expressed in the liver. The first to be 
described and assigned to this group was MUP15 isolated from a liver 
cDNA library (Clark et al., 1985a). The MUP15 gene has diverged 
from the group 1 consensus sequence by approximately 15%. A second 
gene, MUP16, isolated from a genomic clone shows around 5% 
divergence from MUP15. MUP15 also differs from the group 1 genes in 
having a longer signal peptide sequence and a different splice 
configuration between exons 6 and 7. Unlike the group 1 sequences, 
MUP15 contains a N-linked glycosylation site and has been shown to 
code for a glycosylated protein detectable in mouse urine (Kuhn et 
al., 1984; Clark et al., 1985a). MUP16 also encodes a protein 
with the same glycosylation site. It differs from all Mup genes 
cloned to date because of the lack of exon 7 and a large 3' deletion 
(Ma, 1987). Shahan et al., (1987a) isolated sequences identical to 
MUP15 in cDNA clones cLiv4 and cLiv7 from male and female liver cDNA 
libraries respectively. On the basis of the frequency of isolation 
of cDNA clones, it is estimated that this species constitutes about 
10-20% of Mup mRNA in the liver of both sexes. 
Group 4 genes. 
This group constitutes Mup genes that are expressed predominantly 
in the lachrymal and salivary glands. Lachrymal gland Mup mRNA 
constitutes 0.5-1% of total lachrymal gland mRNA synthesised in 
adult males (Shahan & Derman, 1984). In vitro translation of this 
mRNA gives a protein which is significantly more basic than other 
MUPs (Shaw et al., 1983). Shahan et al., (1987a) constructed 
cDNA clones from Mup-specific mRNA isolated from the lachrymal 
gland. Each of the 11 cDNA clones isolated was identical to a clone 
cLacl indicating that all of lachrymal Mup mRNA5 are transcribed 
from this one gene. The unique sequence of cLacl confirms that a 
distinct Mup gene is expressed in the lachrymal gland. Clark et 
al., (1982) isolated a gene 3L2 from a partial genomic clone. 
Extensive rtriction enzyme site homology between BL2 and cLad 
suggest that they are the same gene. 
In the submaxillary gland, Mup mRNA constitutes 0.2-0.5% of the 
total mRNA (Shahan & Derinan, 1984). Mup cDNA clones were 
constructed from the submaxillary RNA of prepubescent male mice. 
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Each was identical in sequence to a single gene isolated in a cDNA 
clone cSmxl (Shahan et al., 1987a) showing that only one Mup 
gene is actively expressed in this tissue. 
Specific oligonucleotide probes were constructed from sequences of 
variable segments in the cloned genes. Probing of mRNA from various 
tissues confirms that cLacl and cSmxl are not expressed in the liver 
(Shahan et al., 1987a). However, mRNA complementary to the cLad 
probe was detected in the lachrymal gland and in low levels in the 
parotid gland. Transcripts with affinity for the cSmxl probe were 
detected in the submaxillary gland and in low levels in the 
sublingual gland. 
The group 4 cDNA clones differ in nucleotide sequence from group 1 
genes by approximately 10%, from group 2 genes by 12% and from each 
other by 7%. 
Summary. 
Tissue-specific synthesis of Mup mRNA is thus brought about by two 
mechanisms: the expression in different tissues of different members 
of the family and the expression of a single gene at various levels 
in different tissues. A summary of the expression of different Mup 
genes in different tissues is shown below. The names of clones are 




TISSUE 	 Mup GENE GROUP 
1 	 2 	 3 
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Liver 	 BS1 (cLivi) 	 MUP15 (cLiv4) 
BL1 (cLiv6) 	 (cLiv7) 












Mouse urinary protein gene organisation. 
Each Mup gene is about 3.9 kb long. Most of the genes fall into 
two main groups, 1 and 2, on the basis of nucleic acid hybridisation 
experiments (Bishop et al., 1982). Between 13 and 15 group 1 genes 
and the same number of group 2 genes are arranged in a pairwise 
divergent orientation. Each gene is associated with 5 kb of 
homologous 5' flanking sequence and 11 kb of 3' flanking sequence 
that contains regions of homology interspersed with non homologous 
sequences. The two 5' regions of each pair are separated by 6 kb of 
non-duplicated DNA. This organisation forms a set of giant imperfect 
palindromes each about 45 kb in size (Clark et al., 1984b; Bishop 
et al., 1985; see Figure 1A). Sequence relationships between 
different palindromes show that they have evolved from a common 
ancestor. This implies that the 45 kb palindrome is not only the 
predominant unit of Mup gene organisation but also the unit of 
Mup gene evolution (Ghazal et al., 1985). The remaining 5 to 9 
Mup genes do not seem to be incorporated into palindromic 
structures. Of these at least 3 are pseudogenes that have resulted 
from a number of different rearrangements (Clark et al., 1984b). 
Thus the number of active Mup genes in the mouse genome is about 
15 (Bishop et al., 1982; Shahan etal., 1987b), roughly the same 
as the total number of different proteins synthesised in all Mup 
expressing tissues. 
Mup gene structure. 
The 3.9 kb transcription unit of the Mup genes contains 7 exons 
(Clark et al., 1984a). The first 6 exons contain the coding 
sequences while the last exon consists entirely of non coding 
sequences. Three different splicing configurations have been found 
which result from the presence of alternative splice sites within 
the untranslated region of exon 6 (Clark et al., 1984a, 1985a; see 
Figure 1B). The most abundant liver Mup transcripts contain part 
of exon 6 and all of exon 7. The smaller and less abundant (by a 
factor of about 10) liver Mup transcripts contain an extended exon 




Organisation and structure of the Mup genes. 
Diagramatic representation of the 45 kilo base unit. Group 1 and 
group 2 genes are approximately 3.9 kb long (shaded). Open 
rectangles are regions of homology between the flanking regions of 
the two groups of genes. The homology is not continuous over the 11 
kb 3' flanking region but is interrupted by regions of non-
homology. Genes are in a head to head (divergent) orientation. The 
45 kb gene pair structure constitutes the evolutionary unit of the 
Mup locus (see text). 
A diagram to show the two main forms of the Mup mRNA. 
The two main Mup RNAs showing their structural relationship to the 
gene BSu6 are shown. Short mRNA contains exons 1-6. Long mRNA 
contains exons 1-5, a short 5' region of exon 6 and the whole of 
exon 7. The greater part of liver Mup mRNA is in the long form and 
nearly all of this is transcribed from the group 1 genes. Exons are 
shown as boxes and the coding regions are shaded. Adopted from Clark 
et al., 1984a. 
A. 	 Group2 gene 	 Group 1 gene 
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products of the Mup genes, long RNA and the two short forms, are 
878, 759 and 741 nucleotides long respectively. The long RNA is the 
prevalent product of slicing of the group 1 gene transcripts (Clark 
et al., 1984a). In contrast the transcript from pMtJP15 is spliced 
to give an extended exon 6 and subsequently a shorter RNA (Figure 
1B). The mBNA specifying sequences of 4 group 1 genes and extensive 
nucleotide sequences of 4 group 1 cDNAs are known (Clark et al., 
1985a, 1985b). These code for a signal peptide 18 amino acids long 
and a mature protein 162 amino acids long. In contrast, the signal 
peptides of four group two genes are all different. They vary in 
length from 19 to 25 amino acids. 
The evolution of Mup genes. 
The predominant organisation of the Mup locus is an array of 45 kb 
domains consisting of group 1 and group 2 genes (Figure 1A). Ghazal 
et al., (1985) describes the nucleotide sequence of the first exon 
of six group 1 and four group 2 genes and derives a consensus 
sequence for each. The consensus sequences differ by 17%. One of the 
differences is between a glycine (GGA) in the group 1 sequence and a 
stop codon (TGA) in the group 2 sequences at amino acid 7. This 
lesion, common to all group 2 genes, is their most significant 
feature. It implies that the mutation was present in a pseudogene 
which was ancestral to all four group 2 genes. 
The complete nucleotide sequence of genes BS6 and BS2 have been 
established (Clark et al., 1985b). The divergence between the two 
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genes is high, approximately 10%. However, within a group the genes 
are very homogenous and differ from each other by only 1-2%. To 
explain this phenomenon an evolutionary model based on the 45 kb 
unit has been proposed (Ghazal et al., 1985). Selection acting 
against an unfavourable newly arisen, actively transcribed group 1 
gene would lead to the elimination of the 45 kb unit which contained 
it. A similar action would apply to the group 2 genes until the 
pseudogene lesion occurred, then further mutations could accumulate 
more rapidly. The two main parts of the amplification unit cannot 
replace another unit. This leads to homogeneity of the units and 
uniformity of group 1 and group 2 genes. To account for the 
tolerance of the group 2 gene it has been proposed that the 




CHAPTER 2: REGULATION OF MUP GENE EXPRESSION. 
Sexually dimorphic expression of Mup genes. 
In BALB/c male mice, Mup mRNA is the most abundant class of liver 
mRNA whilst in the female the most abundant species is serum albumin 
(Clissold & Bishop, 1981). In BALB/c adult male mice, Mup mRNA 
constitutes about 8% of the total liver polyadenylated mRNA. This 
level is five times higher than that of adult female mice (Hastie & 
Held, 1978; Hastie et al., 1979), although expression in females 
may be rather variable (McIntosh & Bishop, 1989). The different 
levels of Mup mRNA in male and female liver reflects different 
rates of transcription as determined by run-on transcription 
experiments (Derman, 1981). Sexually dimorphic expression of a group 
1 BS6/HSVtk transgene is observed in transgenic mice (Al Shawi et 
al., 1988). The male to female ratio was about 10 in 3 out of 5 
transgenic lines. Run-on experiments showed that the different 
levels of HSVtk RNA and thymidine kinase observed are to some 
extent mediated by different rates of transcription. Held et al., 
(1989) also observed differences between the sexes in the expression 
of a Mup(BL6)/SV40 T-antigen transgene although no run-on 
experiments were conducted in this case. 
The lachrymal gland also exhibits sexual dimorphism with respect to 
Mup gene expression. The male lachrymal gland has 5 times as much 
Mup mRNA as female (Shaw et al., 1983). The submaxillary gland 
does not show sexual dimorphism with respect to Mup expression. 
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The effect of testosterone on Mup gene expression. 
Early studies on the regulation of Mup genes came from experiments 
which revealed a group of urinary proteins that exhibit both sex-
and strain- specific phenotypes. The administration of testosterone 
to females resulted in an increased amount of excreted MUP5 and a 
shift to the male phenotype of expressed proteins (Finlayson et 
al., 1965). Livers from female and castrated male mice have reduced 
levels of Mup mPNA, up to one fifth of normal males. This can be 
elevated to normal male levels upon administration of testosterone 
(Clissold et al., 1984). In female mice transgenic for a BS6/tk 
transgene (Al Shawi et al., 1988) the presence of testosterone was 
sufficient to induce increased levels of thymidine kiriase, but not 
to male levels. The data suggests that the increase in transcription 
is mediated by the action of testosterone, via its receptor, on 
sequences within the 2.2 kb BS6 promoter region. 
It has been proposed (Norstedt & Palmiter, 1984) that testosterone 
acts on the pituitary to induce a discontinuous pattern of growth 
hormone production in males, compared with a continuous production 
in females. This determines the sexual dimorphism of the liver. It 
is also suggested that a discontinuous stimulation of growth hormone 
receptors causes a discontinuous release of insulin-like growth 
factor I (IGF-I). This release induces MU? synthesis. A continuous 
stimulation of growth hormone receptors (as in the female ) up-
regulates growth hormone/prolactin receptors resulting in a 
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continuous release of IGF-I. This results in the down-regulation of 
IGF-I receptors and a low production of MUP. 
The action of other hormones on Mup gene expression. 
Regulation of Mup gene expression has been studied in C57BL/6J 
mice by the administration of hormones to mutants or surgically 
altered mice with hormone deficiencies (Knopf et al., 1983; Kuhn 
et al., 1984). To examine the effect of growth hormone, the mutant 
mouse strain little was used. The pituitary glands of these mice 
are insensitive to growth hormone releasing factor and very low 
levels of growth hormone are detected in the serum (Jansson et 
al., 1986). Mup mRNA levels are reduced over 100-fold in these 
mice but are restored to male levels on the administration of growth 
hormone (Knopf et al., 1983). The action of growth hormone in the 
absence of other pituitary controlled hormones was studied in 
hypophysectomised mice which lack pituitary function. Synergistic 
effects of hormones are indicated by the absence of testosterone-
mediated Mup mRNA synthesis and the non additive effect of 
administration of both growth hormone and thyroid hormone. 
Testicular feminised tfm/Y mice, which lack a functional major 
testosterone receptor protein and are relatively androgen 
insensitive, were used to further test the testosterone independent 
induction of Mup mRNA by growth hormone and thyroxine. 
Cooperativity of the two hormones in producing an elevated level of 
Mup mRNA was again observed. These results together indicate that 
Mup genes expressed in the liver are under complex multihormonal 
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control. Further evidence comes from experiments using 
thyroidectomised female mice since the administration of each of the 
hormones testosterone, growth hormone and thyroxine results in 
increased levels of Mup mRNA in the liver and different patterns 
of mRNA translation products. 
Previous reports indicate that rat Y.2u-globulin expression in the 
liver is regulated by glucocorticoids and that cloned genes 
introduced into mouse L cells are regulated by dexamethasone (Kurtz 
1981). Held et al., (1987) transfected L cells with various 
genomic clones of Mup isolated from C57BL/6J and BALB/c mice. A 
low induction of MU? synthesis by glucocorticoid was observed but 
this may have been related to cell physiology. The regulation by 
these hormones contribute to the sexual dimorphism of Mup 
expression in the liver (Szoka & Paigen, 1978; Knopf et al., 1983; 
Norstedt & Palmiter, 1984). Mice transgenic for anc2u-globulin 
genomic clone containing 2 kb of upstream sequence express ct2u-
globulin in adult male liver and preputial gland. Expression can be 
induced by glucocorticoid treatment of ovariectomised mice (da Costa 
Scares et al., 1987). The upstream sequences present in the 
transgene include the elements identified by Addison & Kurtz (1986) 
as being involved in the glucocorticoid induction of ct2u-globuliri 
gene expression in L cells. This suggests that these elements may 
also be involved in the glucocorticoid regulation of a2u-globulin 
in the rat liver, first demonstrated by Kurtz & Feigelson (1978). 
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In the lachrymal gland, testosterone induction tends to be 
independent of growth hormone or thyroxine. Mup gene expression in 
the submaxillary gland does not appear to be under hormonal control. 
The hormonal regulation of mammary gland Mup genes has not been 
studied. It is not known whether the hormonal modulation of MtJPs is 
by direct or indirect action in the particular tissues. 
Tissue-specific expression of MUPs. 
Transgenic mice have been used to analyse DNA sequences required for 
Mup tissue specific expression. Al Shawi et al., (1988) and Held 
et al., (1989) show that the gene sequences necessary for tissue 
and temporal control of Mup genes BS6 and BL6 are located within 
the 5' flanking regions of these genes. Al Shawi et al., directed 
the expression of a Herpes simplex virus thymidine kinase (HSvtk) 
reporter by 2.2 kb of 5' BS6 (group 1) sequences. Expression was 
observed in the liver of male and female mice. In addition the 
regulation of expression by testosterone exhibited sexual 
dimorphism. These are the characteristics of a group 1 Mup gene. 
Held et al., (1989) analysed the tissue specific expression of a 
group 1 Mup (BL6)/SV40 T-antigen hybrid gene. The 5' region 
constitutes 2.5 kb. Expression was observed in male and female 
livers. Preliminary results (Al Shawi et al., unpublished) suggest 
that liver expression is directed by sequences located more than 360 
bp upstream from the Mup CAP site. HSVtk expression in the liver 
was abolished in mice transgenic for this short DNA fragment (see 
Chapter 11). 
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CHAPTER 3: THE EUKARYOTIC PROMOTER. 
Introduction. 
A general strategy for identifying cis regulatory elements has 
been termed reverse genetics. Cloned genes are truncated or mutated 
in vitro and their expression is then studied after transfection 
into cell lines. Detailed molecular analysis of a number of 
different promoters reveals a common pattern of organization in 
genes transcribed by RNA Polymerase B (Grosschedl & Birnstiel, 
1980,1983; Benoist & Chambon, 1981; Dierks et al., 1981,1983; 
McKnight et al., 1981; Everret et al., 1983; McKnight & 
Kingsbury, 1983). Definable structural features include the CAP 
site which identifies the sequence corresponding to the 5' terminus 
of the messenger RNA (Schenk, 1981). At the start point there is no 
extensive homology of sequence but there is a tendency for the first 
base of mPNA to be an adenine residue flanked on either side by 
pyrimidines (Breathnach & Chambon, 1981). This consensus may not be 
a true reflection of CAP structure as it was collated from only 22 
genes. The TATA consensus sequence is located at approximately 30 
bp upstream from the CAP site. It appears to position the location 
of the CAP site. Deletion of the TATA box (with retention of the 
upstream sequences) generates messages with heterogeneous 5' ends as 
seen in the Sea Urchin Histone H2A gene (Grosschedl & Birnstiel, 
1980) the SV40 early genes (Benoist & Chambon, 1981) and the rabbit 
-g1obin gene (Grosveld et al., 1982). In the case of the SV40 
early region, the amount of early mPNA produced does not seem to be 
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strongly influenced while deletion in both the histone and -globin 
genes is a strong down mutation. Deletion of the CAP site does not 
abolish transcription but leads to the generation of new initiation 
sites with lower transcriptional efficiencies. Exceptions to the 
universal presence of the TATA box sequence are the Papovavirus late 
genes and adenovirus-2 E2 gene (Baker & Ziff, 1981) and the so 
called "housekeeping" genes. A number of other elements which appear 
to affect the efficiency of transcription have been categorized. 
These include the CCAAT consensus located at approximately 80 bp 
upstream from the CAP site and regions up to 120 bp away. These 
contain imperfect repeats of 12 to 15 bp of GC-rich sequences 
(Dierks et al., 1981, 1983; Everett et al., 1983). Mutageriesis 
studies suggest that the strength of the promoter is determined by 
the number and type of upstream promoter elements which seem to act 
regardless of orientation. More distant sequences which influence 
transcription are termed enhancers. Originally identified in SV40 
(Moreau et al., 1981; Banerji et al., 1981) they are cis- 
acting DNA segments which dramatically stimulate transcription from 
RNA polymerase B class homologous or heterologous promoters. They 
act in an orientation-independent manner and over long distances. 
Tissue-specific enhancers have recently been identified often lying 
a few kb away from the CAP site. Examples include the mouse albumin 
(Pinkert et al., 1987) and the chicken ovalbumin genes (Kaye et 
al., 1986). In contrast to the SV40 enhancer which is active in a 
variety of cell lines, some enhancers exhibit a host cell preference 
(Spandidos & Wilkie, 1983; De Villiers et al., 1982; Yoshimura et 
al., 1985) and strict cell lineage specificity (Queen & Baltimore, 
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1983). Silencers are thought to have a dominant role in tissue-
specific gene expression. They have been used to explain the mis-
expression of Mup genes in transgenic mice (Al Shawi et 
al.,1988; see Chapter 11). Specific trans-acting proteins are 
thought to interact with silencer sequences to block transcription. 
This is analogous to the way in which prokaryotic repressors 
interact with operators, for example Ga180 and the galactose operon. 
It is generally agreed that in combination with specific cis-
acting DNA elements which bind specific regulatory proteins, these 
various regions constitute a promoter for eukaryotic gene 
transcription. 
DNA elements as recognition sites for trans-acting proteins. 
The Spi binding site. 
Proteins that interact with specific cis DNA recognition elements 
are thought to contribute to the regulation of gene expression. 
Recently many have been identified by gel retardation and 
footprinting assays. Mutational analysis of the SV40 early promoter 
in HeLa cells revealed the existence of a promoter element 
containing the sequence GGGCGG which binds a trans-acting factor 
designated Spi (Dynan & Tjian, 1983a). DNAase I footprint and 
protection studies on mature or mutant SV40 early promoters have 
shown that Spi binds in a sequence-specific manner to the GC rich 
hexanucleotides that occur twice in each 21 bp repeat of the SV40 
early promoter (Dynan & Tjian, 1983b; Gidoni et al., 1985; see 
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Figure 2A). Each binding site occurs once per turn of the DNA helix. 
When the promoter is fully occupied, 5 Spi factors lie predominantly 
on the same face of the DNA helix. The Spi recognition site that is 
closest to the RNA initiation site is typically located 40-70 
nucleotides upstream of the start and despite the asymmetry of Spi 
binding sites, they are functional in either orientation. Kadonaga 
et al., (1987) showed that purified Spi (Briggs et al., 1986) 
requires zinc(II) for sequence specific binding to the DNA. This is 
a feature characteristic of many activator proteins (Chapter 4). 
Spi has been shown to be involved in regulating the expression of a 
number of different genes. These include the Herpes simplex virus 
thymidine kinase gene (McKnight & Tjian, 1986), human 
metallothionein hA gene (Lee et al., 1987a), mouse hydrofolate 
reductase gene (Dynan et al., 1986) and the human heat shock 
hsp70 gene. Spl binding sites are often found near binding sites 
for other transcription factors, for example with the CTF/NF-1 
factor in the HSVtk gene (Jones & Tjian, 1985) and Ap-1 (Lee et 
al., 1987a). This suggests that these factors may act in 
conjunction with each other to modulate the level of transcription. 
DNAase footprint experiments indicate that Spi binds at two GC 
hexanucleotide domains within the HSVtk promoter. One centered 
within a domain dsl and another, in opposite orientation, in the 
dsll domain (see Figure 2B). 
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CpG islands as gene markers. The role of Spi. 
Vertebrate genes, in contrast to invertebrates, are nearly always 
methylated to some extent. A small fraction of the vertebrate genome 
is characteristically non-methylated and constitutes discreE DNA 
domains, usually 1-2 kb long, containing an unusually high number of 
CpG dinucleotides relative to the bulk of the genome (Bird, 1986; 
1987). Many CpG islands are associated with genes eg housekeeping 
genes, particularly at the start site of transcription (Bird, 1986) 
although in a few tissue-specific genes they appear to be present 
entirely downstream of the CAP site. Therefore CpG islands not only 
mark genes but are likely to contain their promoters and S ends. 
The effect of methylation on chromatin structure remains to be 
resolved. However, it has been suggested that the frequent 
association of these CpG islands at the 5' end of a gene reflects a 
preferred site of interaction between DNA and DNA binding proteins. 
These proteins would be prevented from binding to other stretches of 
DNA because of methylation. One candidate for this model would be 
Spi as its consensus contains a CpG dinucleotide and is GC-rich. 
However Dynan (1989) reviews work which shows that the methylation 
of Spi sites does not always inhibit Spi directed transcription. 
The CCAAT motif as a recognition sequence for cellular 
transcription factors. 
A region of approximately 24 bp containing a binding site for a 
protein factor distinct from Spi is positioned between the two Spi 
binding sites of the HSVtk promoter (Figure 2B). This protein has 
been isolated from (1) HeLa cells (Jones et al., 1985b) and (ii) 
rat liver nuclei (Graves et al., 1986). Since the pentanucleotide 
CCAAT occurs within the binding domain, the protein factor has been 
termed CCAAT transcription factor CTF (i) or CCAAT binding protein 
CBP (ii). The CCAAT sequence is required for the transcription of a 
class of cellular genes that include many vertebrate globin gene 
families. The CCAAT element of the mouse -globin promoter interacts 
with yet another promoter element that contains the sequence 
CCACACCCG whereas the CCAAT element of the human (X-globin promoter 
appears to function independently (Charney et al., 1985; Myers et 
al., 1986). The CCAAT element is also found in the heat shock 
elements of Xenopus and human hsp70 genes (Beinz & Pelham, 1986) 
and in the 5' region of the mouse albumin gene (Lichensteiner et 
al., 1987). Although various CCAAT containing elements appear 
similar in sequence, evidence suggests that different proteins are 
capable of distinguishing between them (Dorn et al., 1987). 
Chodosh et al., (1988) describes three related but distinct 
proteins from HeLa cells designated CP1, CP2, and NF-1 which 
specifically recognize particular subsets of CCAAT elements. Binding 
sites for CTF in human Ha-ras and the c-globin promoter were highly 
homologous to sequences which recognised the nuclear factor NP-1. 
This is required for initiation of adenovirus DNA replication in 
vivo (Bernstein et al., 1986). Jones et al., (1987) have since 
shown these factors to be indistinguishable at the polypeptide 
level. 
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The TATA box binding factor TF11D. 
Moncollin et al., (1986) and Fire et al., (1984) have shown that 
at least four general transcription factors BTF1, BTF2, BTF3 and STF 
are absolutely required for accurate initiation by RNA polymerase B 
from the Adenovirus 2 major late promoter (Ad2MLP). The TATA box 
factor BTF1, interacts with a large region of the promoter, 
including the TATA box and initiation start sites, to form a stable 
pre-initiation complex (Shi et al., 1986; Zheng et al., 1987). 
This interaction occurs in the absence of RNA polymerase B and is 
facilitated by a factor STF. Two other factors BTF2 and BTF3 are 
then required for accurate initiation. Cavallini et al., (1988) 
showed that a yeast factor, GAL4, can substitute for the HeLa cell 
BTF1 TATA box factor. This indicates the striking evolutionary 
conservation of trans-acting regulatory proteins and suggests that 
BTF1 may be a ubiquitous factor. 
Hormone responsive elements. 
The hormone responsive elements are closely related 15 bp 
palindromes. The dyad symmetry of these elements suggests that 
nuclear receptors may bind as a dimer, with each receptor molecule 
recognising an arm of the element. Comparison of several functional 
glucocorticoid responsive elements (GPEs) has indicated a consensus, 
5'-GGTACANNNTGTTCT-3', which differs in only 2 bp from that of the 
oestrogen receptor (Green & Chanibon, 1988). While no clear consensus 
sequence has yet been defined for the progesterone and androgen 
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receptor elements, a GRE 15-mer is able to mediate induction by 
progesterone, androgens and mineralocorticoids (Beato et al., 
1989). This suggests that the hormone responsive elements are a 
family of related sequences which have co-evolved with a receptor 
family. In terms of structure and function it seems that steroid 
hormone receptors can be divided into two groups: the 
glucocorticoid, mineralocorticoid and androgen receptors being more 
closely related to each other than the oestrogen, thyroid, retinoic 
acid and vitamin D receptors (Chang, 1988 and references therein). 
The SV40 enhancer and early promoter region. 
Enhancers also contain short discrete DNA sequences which 
specifically interact with proteins. In Simian Virus 40, an AT-rich 
region which bears similarity to the TATA box of eukaryotic genes, 
is believed to fix the early mRNA start sites (Ghosh et al., 
1981). Flanking this region are three direct repeats of a GC-rich 
21 bp sequence. Each contains two GC hexanucleotide sequences which 
bind the transcription factor Spi. Complete deletion of these 
repeats severely affects early promoter function (Everett et al., 
1983). Two additional 72 bp repeats are positioned upstream. Removal 
or disruption of both these elements reduces early transcription, 
but deletion of a single repeat does not have a substantial effect. 
Unlike the 21 bp repeats, the 72 bp elements can activate 
transcription when placed up to 1 kb either side of a transcription 
unit (Moreau et al., 1981). These properties are consistent with 
those of an enhancer element. However systematic mutagenesis of the 
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SV40 enhancer region (Zenke et al., 1986) shows that the 72 bp 
sequence is not the SV40 enhancer. Enhancer activity is confined to 
a 100 bp region, which includes the 72 bp sequence and essential 
upstream sequences. It can be dissected into two domains A and B 
(Maniatis et al., 1987; see Figure 2A). These domains exhibit 
little enhancer activity on their own. Irrespective of relative 
orientation and to some extent the distance between them, their 
association results in a 400-fold enhancement of transcription. 
Enhancer activity can also be generated by duplication of either 
domain. Another study identified 3 separate domains A, B and C (Herr 
& Clarke, 1986; Clarke & Herr, 1987). The A and C domains together 
constitute the B domain named by Zenke above (Jones et al., 1988). 
The activity of each domain is in turn dependent on the integrity of 
specific sequence motifs (Figure 2A). These include the P element 
which binds the transcription factor Ap-1 (Lee et al., 1987a). The 
GT1 and GTII domains are highly homologous but bind specific 
proteins such as Ap3 (GTI) and Ap5 (GTII) (Jones et al., 1988). 
The enhancer also contains a direct repeat of the Sph/Octamer motif 
ATTGCAT which binds a range of nuclear proteins (Jones et al., 
1988; Sturm et al., 1987). The host range of enhancer activity may 
depend on the particular motifs present since the corresponding 
factors may be tissue specific. Consistent with this theory, 
Davidson et al., (1986) have shown that different sequence motifs 
within the SV40 enhancer are recognised by different factors present 
in B cell and HeLa cell nuclear extracts. Schirm et al., (1987) 
have shown that all of the sequence motifs may have different 




Cis-acting control sequences of the SV40 promoter. 
The 8V40 early promoter constitutes three 21 bp repeats each of 
which contains two GC hexanucleotide motifs which bind the 
transcription factor Spi. The 72 bp repeats harbour cis regulatory 
elements for enhancer activity and late promoter funtion. The SV40 
enhancer spans 100 bp. It is composed of two domains A and B which 
contain DNA specific elements recognised by a variety of cellular 
proteins (Zenke et al., 1986). 
A schematic diagram of the cis acting control sequences of 
the HSVtk gene. 
Cis-acting control sequences of the HSVtk gene include a TATA 
box and a cellular transcription factor (CTF) binding site 
sandwiched between two GC hexanucleotide Spi binding sites. The 
sites fall into two functional domains dsl and dsll as shown. 
(Adopted from McKnight & Tjian, 1986). 
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Summary. 
The activity of promoters and enhancers is determined (i) by the 
types of control elements present and (ii) by the interaction of the 
regulatory proteins that recognise these control elements. A 
considerable degree of promoter diversity can be generated by 
combination of a relatively small number of trans-acting elements 
on cis-acting sequences. How the factors that recognise enhancers 
can act on promoters over a large distance has been proposed in 
several models (Serf ling et al., 1985; Schaffner, 1989). Recent 
observations are consistent with a model in which transcription is 
stimulated by interactions between proteins bound to the promoter 
and enhancer with the looping out of the intervening DNA (Ptashne 
et al., 1986). The binding of other repressors and activators, DNA 
polymerase is then mediated by this initial looping out. A second 
hypothesis for transcriptional activation is that the binding of 
activators causes some local change in chromatin structure which 
renders its TATA box region accessible to binding factors. These 
sites can be identified as being sensitive to attack by DNAase 
(Eissenberg et al.,1985). 
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CHAPTER 4: TRANSCRIPTIONAL ACTIVATOR PROTEINS. 
Introduction. 
The mechanism by which a protein bound to a site many base pairs 
from a gene activates transcription remains unclear. The most likely 
theory involves an activator protein which binds to cis-acting 
elements upstream from the gene and interacts with another protein. 
This secondary protein can be either bound to an initiation complex 
which could include the polymerase or can facilitate the binding of 
the polymerase to the DNA in the region of the transcription start 
site. The intervening DNA loops out to facilitate the reaction 
(Ptashne, 1986; 1988). The cis-acting sites could for example be 
enhancers as found in mammalian cells. In lower eukaryotes such as 
yeast, elements called upstream activator elements (UAE5) are 
required for efficient transcription. When analysed using reverse 
genetic techniques they function independent of orientation and are 
effective at some distance from the gene. Like mammalian enhancers 
they are the sites for the binding of specific trans-acting 
factors for example Ga14 and GCN4 found in yeast. 
DNA binding proteins and transcriptional activation. 
A comparison of different DNA binding transcription factors 
indicates that several types of protein domains have been adopted to 
mediate sequence-specific protein-DNA interactions. One prevalent 
structural framework for binding DNA is the so called "zinc-finger" 
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motif, which has been found in a large number of established and 
putative transcription factors (Klug & Rhodes, 1987). Another DNA 
binding structure that has been identified is the horneodomairi, first 
recognised in homeotic genes responsible for regulating Drosophila 
development but now also found in a variety of other transcriptional 
control proteins from yeast to man (Levine & Hoey, 1988). In 
general, the binding of these domains to their DNA recognition 
elements is not sufficient to trigger transcription, additional 
protein sequences are necessary for transcriptional activation. 
These protein domains are thought to interact with RNA polymerase II 
or other ancillary factors of the transcription complex. One class 
of activation sequence is characterised by a high content of 
negatively charged amino acid residues that may be present in an 
amphipathic alpha helical structure (Ptashne, 1988). However, it has 
become apparent that there may be multiple types of transcriptional 
activating sequences. Recent evidence indicates that the mammalian 
DNA binding protein Spl activates transcription through a distinct 
motif, characterised by a high glutamine content (Courey & Tjian, 
1988). These studies suggest that a number of different structural 
designs can be used for transcriptional activation, as in the case 
of DNA binding. The DNA binding and transcriptional activation 
domains of activator proteins are clearly seperable as shown for 
example in domain swap experiments on the yeast proteins Gal4 and 
GCN4 (Keegan et al., 1986). 
DNA binding domains. 
1) Helix-turn-helix. 
Crystallographic studies determined for the coliphage 434 repressor, 
the cro protein of bacteriophage lambda and the CAP protein of E. 
coli, have revealed the existence of conserved a helical structures 
which computer modelling studies suggest are the DNA binding sites 
for these proteins (Laughon & Scott, 1984; Pabo & Sauer, 1984). The 
DNA binding structure comprises of two U, helices connected by a 
turn. Most of the DNA contacts made by cro, repressor and CAP 
occur on one side of the double helix. However, lambda repressor 
contacts both sides of the double helix by using a flexible region 
of protein to wrap around the DNA (Pabo & Sauer, 1984). 
Many other prokaryotic and some eukaryotic DNA binding proteins 
share a motif similar to the helix-turn-helix. Prominent among these 
are the homeobox containing proteins. The homeodomain is present in 
the products of early developmental genes of Drosophila and other 
species and its sequence is highly conserved in otherwise unrelated 
proteins. That DNA binding specificity is a property of the homeobox 
has been shown by homeobox "swap" experiments (Hoey & Levine, 1988; 
Levine & Hoey, 1988) and the evidence that point mutation and 
inframe deletions within the homeobox can completely abolish binding 
functions (Desplan et al., 1988; Levine & Hoey, 1988). This 
evidence supports the idea that many of the developmental genes 
encode transcriptional regulators. 
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According to the current model based on molecular and genetic 
data and on the crystal structures of the lambda and 434 repressors 
and the CR0 protein, the N-terminal part of the recognition helix 
fits into the major groove of DNA. Amino acids on one face of this 
helix establish hydrogen bonds and van der Waals contacts with the 
base pairs. The specificity-determining residues occupy positions 1 
and 2 in the first turn of the recognition helix and positions 5 and 
6 in the second turn (Berg, 1986; Anderson et al., 1987; Wolberger 
et al., 1988). An adjacent cthelical region contacts the DNA 
backbone and may help to orientate the "recognition" helices. 
The homeodomain was initially expected to bind to DNA in a 
conformation similar to that described for prokaryotic proteins. 
Indeed, homeodomains of such proteins as ftz (fushi tarazu), which 
have very similar recognition helices to these prokaryotic proteins, 
can recognise the same sequences (Desplan et al., 1988). This is 
consistent with the idea that the helix-turn-helix is important in 
generating DNA specificity. Homeodomains from more diverged genes 
for example prd (paired) do not bind to the same recognition 
sequence (Hoey & Levine, 1988). Treisman et al., (1989) 
demonstrate that the specificity of this homeodomain is critically 
dependent on the nature of the amino acid at position 9 of its 
recognition helix. This observation was also observed for the bicoid 
activator protein (Hanes & Brent, 1989) supporting the model that 
this amino acid is the major determinant of the specificity of bona 
fide homeodomain proteins. Studies on the homeobox protein paired 
(Treisman et al., 1989) also suggest that in addition to the 
specificity directed by residue 9, individual homeodomain proteins 
may have other complexities in their interaction with DNA. The 
region just C-terminal to position 9, which is the most highly 
conserved part of the homeodomain, contains a stretch of 4 lysine or 
arginine residues. This region forms a helical C extension of the 
recognition helix (Otting et al., 1988). It is possible that this 
very basic region can interact closely with the phosphates of the 
DNA backbone, tilting the recognition helix to bring the amino acid 
at position 9 closer to the major groove than in the 434 repressor. 
This could provide an explanation for the conservation throughout 
evolution of the differences between the various classes of 
homeodomains outside the recognition helix. 
2) zinc-finger domains. 
A number of DNA binding domains that are clearly different from the 
helix-turn-helix motif have been discovered. Prominent among these 
are domains that are structurally organised around zinc ions 
coordinated to invariant cysteines and/or histidine residues (Evans 
& Hollenberg, 1988). These domains are collectively referred to as 
"zinc-finger" domains. However, more detailed analysis clearly 
indicates that there are several distinct classes of domains that 
share the property of containing zinc ions but need not share 
additional structural characteristics: 
i) Transcription factor lilA-type proteins. 
Originally discovered in Xenopus laevis, transcription factor 
TFIIIA typifies this type of activator protein. They contain a 
finger motif tandemly repeated a minimum of two times with a 7-8 
amino acid linker seperating the units. Each finger unit contains a 
pair of cysteine and histidine residues separated by a loop of 
approximately 12 amino acids (Evans & Hollenberg, 1988). Such 
fingers are commonly referred to as C 
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 H 2  type. This module 
can be strung together to form proteins that can recognise long 
stretches of DNA sequence. The repetitive nature of the fingers 
suggests a structure in which amino acids at the tip of each finger 
loop interact directly with the DNA helix. For example, each of the 
9 fingers of TFIIIA have been shown to interact with approximately 5 
nucleotides (Fairall et al., 1986) with adjacent fingers 
interacting with contiguous stretches of DNA. In contrast Spi which 
has 3 fingers binds only to a 10 bp nonpalindromic GC box sequence 
rather than to the expected 15 bp, but with high affinity. 
Structural characterisations of these domains based on the 
predictions from amino acid sequence (Berg, 1988) has revealed a 
structure that includes an a helix that could lie in the major 
groove of the DNA to make specific contacts, analogous to those of 
the helix-turn-helix proteins. The precise correlation between 
finger number, nucleotides bound and affinity remains to be 
elucidated. 
ii) The steroid receptor type proteins. 
These proteins have non-repetitive fingers and have a variable 
number of conserved cysteines available for metal chelation. They 
include the yeast transcriptional factor Ga14 which has 1 finger 
incorporating 6 cysteines, and steroid receptors. Steroid receptors 
contain 2 apparently unrelated fingers coded for by separate 
exons, containing 4 and 5 cysteines respectively (Evans & 
Hollenberg, 1988; Berg, 1989). Each finger is separated by 
approximately 15-17 amino acids. The binding sites for this class of 
protein, collectively referred to as hormone responsive elements 
(HRE's), are relatively short and contain dyad symmetry implicating 
dimer formation for DNA binding (Berg, 1989). Recently Umesono& 
Evans (1989) showed that two distinct regions outside the loops of 
the two zinc fingers are critical for sequence recognition between 
the glucocorticoid, oestrogen and thyroid receptor elements and that 
this implicated region may form a recognition helix that is 
potentially analogous to those in the helix-turn-helix and TFIIIA 
type proteins. Further evidence (Berg, 1989) suggests that the first 
zinc finger and critical adjacent residues of steroid receptors are 
involved in protein-DNA interactions whereas the second zinc finger 
may be involved only in protein-protein interactions. In addition 
the binding specificity of steroid receptors can be altered by 
simple amino acid changes in the first zinc finger. 
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DNA activating domains. 
The activating domains of many DNA activating proteins including the 
glucocorticoja receptor (Godowski et al., 1988; Hollenberg & 
Evans, 1988) the yeast activator Ga14 (Ma & Ptashne, 1987) and GCN4 
(Hope & Struhi, 1986) and the HSV activator VP16 (Sadowski et al., 
1988) have a highly acidic character produced by a propensity of 
negatively charged amino acids with an ill-defined structure. Ma & 
Ptashne (1987) found that moderate transcriptional activation could 
be achieved by fusing the Ga14 DNA binding domain to random 
polypeptjdes encoded by fragments of genomic E. coli DNA. 
Activating sequences were shown to contain an excess of acidic side 
chains with the strength of activation related roughly to the amount 
of negative charge. 
The role of these unstructured activating domains in the formation 
of transcriptional activation complexes may be determined from the 
structure of the eukaryotic RNA polymerase II (RNA Pol II). It has 
been suggested that the long heptapeptjde repeat tail at the carboxy 
terminus of the polymerase II large subunit might contact sequence 
specific transcription factors (Allison et al., 1985; Zehring et 
al., 1988) perhaps through hydrogen bonding (Sigler, 1988). Nearly 
all the amino acid side chains of the repeating blocks are 
hydrophilic (primarily hydroxyl groups and never acidic) and this 
structure is highly conserved among many eukaryotes and prokaryotes 
(Allison et al., 1988). The unique secondary structure proposed 
for this domain is one which projects out of the globular polymerase 
polypeptide. The cleavage of repeating elements from the catalytic 
domain of RNA Pol ii is consistent with this observation (zehring 
et al., 1988). The RNA polymerase is postulated to interact with 
one or more activating acidic regions by hydrogen bonding between 
the carboxylate groups of the activating domain and the hydroxyl 
groups of the RNA Pol II subunit. The "non-specific" nature of the 
interaction means that RNA Pol II can function in a wide variety of 
different transcriptional-activation systems. 
Once RNA Pol II has been positioned accurately on the template it 
must be released from the initiation complex to proceed with 
transcription. The above model suggests that this could be 
accomplished by phosphorylation of the hydroxyl groups at or near 
the interaction sites of the activator domains. This would break the 
hydrogen bond contacts and may concurrently activate the 
transcriptional function of the enzyme (Sigler, 1988). 
ii) Non acidic activating domains. 
Analysis of Spi mutants reveals multiple distinct regions outside of 
the DNA binding domain that are responsible for mediating 
transcriptional activation (Courey & Tjian, 1988). The two most 
active domains consist of unusual structure with a very low charge 
density, but a strikingly high glutamine content. A number of 
other known and suspected transcription factors also contain 
glutamine-rich segments for example the Drosophila zeste gene 
which has been shown to bind the ultrabithorax promoter (Biggins et 
al., 1988) and the products of a number of homeobox containing 
genes such as Antp (Schneuwily et al., 1986) and Cut 
(Blochlinger et al., 1988). The amide moieties of the glutamine 
side chains can be envisaged to participate in hydrogen bonding to 
the RNA polymerase or other activating proteins. Glutamine may be 
unique in being able to reach a contact point in a depression or 
groove of another protein which would be inaccessible to other 
residues due to structural constraints. In addition the activating 
regions of the human oestrogen receptor does not contain any 
stretches of acidic amino acids (Webster et al., 1989; Tora et 
al., 1989). Thus it appears that acidic regions are not the only 
transcriptional activation motif. Tora et al., 1989 propose that 
different activating domains may interact with different components 
of the basic initiation complex whose formation requires several 
ancillary proteins in addition to RNA polymerase II (Buratowski et 
al., 1988). 
Summary: Trans-Activating Proteins 
The function of trans-activating proteins is to stimulate the 
formation and/or action of transcriptional preinitiation complexes. 
The core of these complexes consist of the promoter-binding 
proteins, e.g. TFIIIA, on which the RNA polymerase depends for 
correct placement and orientation with respect to the start site of 
transcription. The activating proteins are targeted to specific DNA 
sequences for example HRE's usually by a specific DNA binding domain 
on the same polypeptide. 
Ligand binding receptors. 
One group of proteins engage in the initiation of transcription from 
certain genes only in response to the specific binding of ligands 
to them. They include factors which can bind steroids, thyroxine, 
retinoic acid and vitamin D. The structural homology observed in 
these proteins suggests that they have all evolved from a common 
ancestral gene (Evans, 1988). Ligand binding receptors have three 
functional domains, the DNA binding domain, the activating domain 
and a unique ligand binding domain. 
The ligand binding domain is characterised by a large number of 
hydrophobic amino acids. The binding of a ligand to this site 
results in an activation of the protein to bind DNA. Control of the 
glucocorticoid receptor is governed by the protein HSP90 which binds 
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to it and prevents it from entering the nucleus (Denis et al., 
1988 and references therein). The hormone dexamethasone dissociates 
the complex and allows the receptor to move into the nucleus and 
activate transcription by uncovering specific DNA binding sites. In 
the presence of hormone, binding of the ligand appears to involve 
the dimerization of the receptor which is necessary for the 
activation of transcription (Green & Chambon, 1988). The oestrogen 
receptor is also believed to be inhibited by HSP90 (Sabbah et al., 
1987). 
The major characteristics of a hypothetical nuclear activating 
protein are summarised in Figure 3. 
Control of gene activator proteins by Phorbol Esters: The Ap-1 
transcription factor. 
The expression of some genes is influenced by external chemical 
stimuli for example phorbol esters. Phorbol esters, such as 12-0-
tetradecanoyl-phorbol-13- acetate (TPA) are potent tumour inducers. 
Among the genes whose expression is altered by TPA are the cellular 
proto-oncogenes c-fos, c-myc, c-sis and collagenase. Angel et 
al., (1987) show that promoters of TPA-inducible genes contain a 
common cis element which can confer TPA inducibility on 
heterologous promoters via a TPA modulated trans-acting factor. 
These cis-acting elements also bind the cellular protein Ap-1. Lee 
et al., (1987) demonstrated that multiple Ap-1 binding sites can 




A sununarv of the characteristic features of a Nuclear Activatin 
Proteinand its hypothetical structure. 
Ligand binding domain. 
The binding of a ligand (X) (eg dexainethasone) to this site may 
activate the protein receptor by the displacement of an inhibitory 
protein (Y) (eg HSP90). 
DNA binding domain. 
The region is well structured and characterised by projections of 
amino acids anchored by zinc. Multiple copies of the zinc fingers 
increase DNA interactions to give multiple DNA binding specificities 
and bring distant DNA sequences together through their interactions. 
Activating domain. 
A poorly structured acidic region with a predominance of negatively 
charged amino acids. These have the potential to interact with the 
protein/polymerase complex (D) by the formation of an amphipathetic 
alpha helix. 
E) Specific DNA sequence motifs. 
These are recognised by specific nuclear activator proteins (eg Sp-
1, Ap-1, hormone receptors, Ga14). 

transfection into HeLa cells. A point mutation which abolishes the 
cis element activity also strongly disrupts Ap-1 binding. This 
suggests that the induction of genes via phorbol esters is mediated 
by the binding of Ap-1 to specific DNA elements. Ap-1 may also have 
a role in establishing a basal level of traniption in conjunction 
with other cellular proteins for example with Spi in the SV40 (see 
Figure 2A) and human metallothionein promoter (Lee et al., 1987b). 
Phorbol esters are considered to exert their effect on gene 
expression in a pathway involving the activation of protein kinase C 
(Nishizuka, 1984). This enzyme may regulate gene transcription by 
the phosphorylation of Ap-1 itself or of an inhibitory protein which 
regulates its activity (Angel et al., 1987). Corssi et al., 
(1988) have shown that c-fos induction by phorbol esters involves 
a trans-acting serum responsive element in a pathway involving 
adenylate cyclase. 
Evolution of transcription factors. 
The large subunit of RNA polymerase B is conserved between yeast and 
man. Recent research has found that upstream regulatory factors also 
exhibit interspecies conservation. Kakidani & Ptashne (1988) show 
that the yeast transcriptional activator Ga14 can activate a TATA 
box containing promoter in HeLa cells. The oestrogen receptor has 
been shown to activate a similar promoter in yeast (Webster 1988; 
Metzger et al., 1988). In addition a factor which can functionally 
substitute for the mammalian TATA box factor (TF11) has been found 
in yeast (Cavallini et al., 1988; Buratowski et al., 1988). The 
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products of the human proto-oncogenes c-fos and c-myc or 
oncogenes v-fos and v-myc can activate transcription in yeast 
when fused to the DNA binding portion of the LexA protein (Lech et 
al., 1988). The JUN oncoprotein, which causes sarcoma in chickens, 
bears a region of extensive homology with the DNA binding portion of 
the yeast GCN4 protein. This suggests that JUN may bind to DNA in a 
sequence specific manner, recognising the same sequences as GCN4 
(Struhi, 1987). The avian JUN protein and the c-fos protein 
(Rausher et al., 1988) have a similar DNA binding specificity to 
the mammalian Ap-1 protein implying that they may be derived from Ap-
1. The thyroid receptor also shows extensive homology to the viral 
oncogene erbA (Evans, 1988 and references therein). These results 
together indicate an ancestry of yeast, avian and mammalian 
transcription factors. More importantly it implies that the 
oncogenic state in some cases may be due to the altered expression 
of genes coding for activator proteins. 
Activator protein interactions. 
DNA binding of transcriptional activator proteins brings to the DNA 
in the vicinity of the gene an activating region which interacts 
with some component of the transcriptional machinery. This 
interaction promotes transcription. The activating region might also 
interact with the target protein freely in the nucleus when neither 
is bound to the DNA. The activator proteins, which differ only in 
the specificity for a DNA binding site, can compete for the same 
target protein. If present in large concentrations, those activators 
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which lack the necessary DNA binding sites may titrate out all of 
the target proteins. This would lead to inactivation of the gene 
whose activating molecules bear the binding site. This hypothesis 
has been termed "squelching" and has been used to explain why strong 
activators such as those produced during viral infections are only 
expressed transiently (reviewed in Ptashne, 1988). To overcome this 
otherwise detrimental effect to the cell it has been supposed that 
cell activators may work cooperatively with one another. A very 
strong activating region is produced when a number of cell 
activators are bound to the DNA whilst each one in isolation is too 
weak to have much effect on binding the target protein when unbound. 
In such a system any two eukaryotic activator proteins can work 
synergistically because they simultaneously make contact with the 
target protein (Kakidani & Ptashne, 1988; Schaffner, 1989). The 
typical gene, however, bears in its vicinity an array of distinct 
binding sites for regulatory proteins (Maniatis et al., 1987). 
Attaching these sites to a second gene in place of its ordinary 
regulatory elements does not inactive the gene, but rather confers 
on it the pattern of expression of the first gene. From this 
evidence it seems that the total number of activators is small 
compared with the number of genes in higher eukaryotes. Tissue-
specific expression is accomplished by the interaction of different 
combinations of transcription factors with physiological stimuli. A 
target protein may become attached to one or more protein activators 
which facilitates the binding of the polymerase. Any activators 
which simultaneously touch the target protein will work 




DNA structure of the Mup BS2 promoter. 
On the basis of nucleic acid hybridisation experiments, the Mup 
genes can be subdivided into two main groups group 1 and group 2. 
Each group has about 15 members. A small number of other genes exist 
which belong to other groups (see Chapter 1, Bishop et al., 1982). 
The full sequence of the transcription unit of a group 1 gene BS6, 
and a group 2 gene BS2, have been determined along with about 700 bp 
of flanking sequence (Clark et al., 1985b). While the available 
evidence indicates that all group 1 genes are true genes, all of the 
group 2 genes so far examined are putative pseudogenes. BS2 carries 
three lesions in its protein coding sequence and could not be 
translated to yield a protein with the molecular weight of MU? 
(Clark et al., 1985b). Studies with a synthetic oligonucleotide 
probe, specific for BS2, failed to pick up any transc'Ipts from this 
gene (McIntosh & Bishop, 1989; Shahan et al., 1987b). 
It does not necessarily follow from these observations that the 
promoter sequences of the group 2 Mup genes are redundant in their 
capacity to initiate transcription from the putative BS2 CAP site. 
Sequence analysis of both BS6 and BS2 show that both genes possess 
all the sequences recognised to be essential for this event (see 
Chapter 3). Alignment of the BS6 and BS2 sequences to maximise 
homology show that both genes possess a TATA consensus sequence at 
position -31 bp. The CAP site of BS6 has been accurately mapped by 
primer extension and SI nuclease protection experiments (Clark et 
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al., 1985b) and sequence homology has placed the BS2 CAP site at 
the same position. In addition both genes contain identical CCCAT 
sequences at position -109 bp (BS6) and -77 bp (BS2). The two gene 
sequences show an 11.1% divergence over the 51 flanking region and a 
divergence of 13.4% for the full sequence (Clark et al., 1985b). 
The BS6 and BS2 promoters contain important sequence 
differences. 
The C(A)N  region. 
The BS6 and BS2 promoters contain sequence differences which may 
contribute to the transcriptional and translational efficiency of 
each promoter and the observed patterns of tissue-specific 
expression. The most prominent differences in sequence occur within 
an adenine (A) rich region just 5' of the TATA box from positions - 
47 to -93 bp. This region contains primarily A or C(A)N 
nucleotides and varies in length in the different clones from 15 
(BS2) to 46 (BS6) nucleotides (see Figure 4A; Clark et al., 1985b; 
Held et al., 1987). Tissue-specific expression studies in 
transgenic mice show that this region is most likely concerned with 
the strength of the promoter rather than governing tissue 
specificity (Al Shawi et al., 1988 & unpublished results). Repeats 
of this nature have been observed in other genes. The 5' flanking 
region of genes encoding mouse complement C4 and the related 
testosterone regulated sex-limited protein also have a high degree 
of overall homology (95%) (Nonaka et al., 1986). However, the sex-




Sequence alignment of the A-tract region located from -40 to - 
90 bp upstream of the Mup genes initiation site. 
Group 1 genes: BS1, BS6, BS109-1, BS5, BL7, BL1, CL8, CL11. 
Group 2 genes: BS2, BS102-2, BS109-2, BL25. 
Rat gene, (X-2u globulin: A2u.91. 
To show the DNA sequence signals present in BS6 and BS2. 
Consensus sequences for the transcription initiation * are taken 
from Breathnach & Charnbon (1981) and for the translation initiation ** 
from Kozak (1984a). 
SIGNAL 	 CONSENSUS 	BS6 	 BS2 
Transcription *GGYCAATCT GACCCATAC GACCCATAC 
Initiation. (-80) (-109) (-77) 
GNGTATAWAWNG GAGTATATAAGG 	GAGTATATGAGG 
(-30) (-31) (-31) 
Translation **CCRCCATG CCAAAATG ACCAAATG 
Initiation. (+67) (+66) 
Translation Exon 6: TGA Exon 1: TGA 
Termination. (+2854 bp) Exon 3: TAA 
Exon 3: TGA 
(+156, 	+1422, 	+1482 bp) 
Regulatory sequence motifs found within the Mup promoter. 
The approximate positions of these motifs refer to the BS6 and the 
BS2 sequences. The reverse strand of the consensus is denoted "rev" 
and the lower case letters refer to mismatches with the consensus 
sequence. Subscripts below the motifs indicate those genes which 
differ from the sequence shown. (Ghazal, 1986). 
Ul 
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I 	GGGAAGAGG. ATAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACAAACA AACAAACAAAAAAAAAAAAAAAAAAAAAAAACCCACTGAACCCAGAGA&1ATA1 AAGI 
&6GAA&AGGG. AAAAAAAAAAAACAAAACAAACAACAACAACA AAAS.A AAAA 	 CCC11 GAACCCA&ASAL3TATA1 AAGG 
tS 09-1 	G&GAA&AGG... AAc AAAAACAAc ACAACAACA CAAAACA.AAAAAA AlA . . CCGCl5AACTCAGA&AT1AATAAG& 
5&AAGAGGG. A4AAAA4AAACAAAACAAACAACAAAACAAAAAAAAAA 4A 	
-C 
CCCGCISAAACCAGA&AG1 AlA! AAGG 
LL 7 	AlA AGGI. AAAAAA AAAAA AAACAACAACAACAACAAA4AAAA A • CCC6CTGAACCCA&AGA11A1AT A6G 
I'll
6GGAAGAGGG. AAAAAAAAAAAAAAAAAA 	 . CACT&AACCCAOAGAGTAIAIAAIG 
CLA 	&G&AA6AGGI. AAAAAAAAAAAAAAAAA.........................................................CAc IAAACCCAAABAGTAIAIAAG6 
CLI I GGGAASAGG6. AAAAAAAAAAA4AAAA........................................................CCCACTGAACCCAI3AGAGTATAIAAGG 
A&AAA6 ..... AAAAAAAAAAAAAAAA ........ ................................................CCCACIGAACCCAAAGAIITAT AT GAGS 
S 10'-2 	AG&AAG.....AAAAAAAAAAAA.............................................................CCACTGAACCCAGAGAG1ATATAAGG 
SIO9-2 AGGAAG.....AAAAAAAAAAA ................ .............................................CCCACIGAACCCAGA!AG1AIATAAGG 
L2 	AGAAAG.....AAAAAAAIAAAA ............ ................................................ CCCACTIIAACCCAGAGAGIATAIAAGG 
A2. 91 AAGAAGG. . . .AAAAAAAAACAC ............ 
...... ...... ...... C&AA C AGA&AGAG! A
PROX APPROX 
FNlT/RE&LATY 	ALE1 ENSUS SITES GROtP I &)9 POSITION ORDUP 2 8ES POSITION 
tèclw Factor 2 Tae.-,.4cyCN, a TTBCNd,CCA -305 GTGcCN,.CCA -270 
(P1) r.v>KTU8.CC* b 8TIIAtN,.CCA 225 
C TaTC 18 T8OsTCAA -135 
d TØ8L8cCAC 
7BG8CCAC +240 
4 TTN.CC* +285 TT8AAN.CCP *315 
t1 Rwaponsive E1.nt C9TrTeYYC8 * .8GGatCG -710 
r.v1Y8C8 2 GATQCIAG0 660 
3 CCcTBCACC.B 5*5 
(Pal Indru) 4 CaGATcC'8t -315 aaT8CATTaS -480 
S a8ttTBC8G 1,5 C60TCG -280 
4 CTAATBCAtAG9 +430 
Lnhanc.r C. S.qu,c, ETBBWWWB CTATCCcC -*30 IL) 2 C.I.  -320 
3 C*ATCCAt -270 CaArCCAt -185 
4 CATTCCC -140 tATTCCAC -110 
S cac -75 
hCac-tiCøjd j0V1 	fl8TBTYCT I tTB+ACc-ISTGTCCT ..535 
LI ...nt ,-.y)ACR)acC 3 CTaTCAtACtTBTCCT -380 CT.T-A-CAtACtI8TCCT -340 
() in PSI • 
3 C+OTTCAQTCTBT&CT -360 
4 9GACAc..M2gp9 -25 GACA.Bc..A69A5 -25 
CCAAT b— PSYCAATCT SaCCcATaCa -113 B+CCCA!.C. -81 
S1in p.nas PWZCYYCACM PA.aC*ttCC -147 	. BAu.tAttCC -lOS CwIw..d -100 r.gt 
23-25bp up.tr.a. .f 
CCMT b— 
apt keeocaBy Odom NDNE 
Mast oh=k LI .sant CT)4TTDA8 10€ NOW 
DEE) 
containing ACACCC and ACAC repeats respectively, suggesting that 
simple repetitive sequences may play some role in differential 
regulation of these genes. Also, C(A)N repeats or A-rich 
regions have been implicated in the formation of bent DNA in 
trypanosome kinetoplast DNA (Wu & Crothers, 1984) and at a 
Saccharomyces cerevisiae autonomously replicating sequence (Snyder 
et al., 1986) and may play some regulatory role. 
The TATA box sequence of BS6 and BS2 compared. 
Another feature which discriminates between the two genes is an A to 
G transversion at position 6 in the TATA box sequence of BS2 
(TATATAA (BS6): TATATGA (BS2)). The BS6 sequence conforms with the 
consensus of Breathnach and Chambon (1981) derived from 50 different 
genes (Figure 4B). However, none of these genes possessed a G in the 
6th position. This transversion may affect the strength of the BS2 
promoter or totally abolish its function of fixing the initiation of 
transcription at the CAP site. Interestingly the feline c-myc gene 
(Stewart et al., 1986) and ovine -lactoglobulin gene (Ali & 
Clark, 1988) exhibit the same G nucleotide at position 6. The TATA 
box sequences are TATATGC and TATAAGG respectively. Neither of these 
sequences affect the transcription of the gene. Primer extension 
studies on both of these RNAs have unambiguously defined the 5' 
terminal sequences which constitute the CAP sites approximately 30 
bp downstream of the two TATA boxes. 
Other differences between the BS6 and BS2 sequences include: i) a 
small duplication of 2 bp in the slice acceptor site of intron 6 
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that may favour the formation of observed short form mRNA, ii) An 
alteration in the translation initiation signal CCAAA to ACCAA that 
may impair translational efficiency (Figure 4B) and iii) An inframe 
increase in the length of the signal peptide region. 
Transcriptional activator protein binding sites in the Mup 
promoter. 
The likelihood that tissue specific factors may be required for 
Mup promoter activity is strengthened by an examination of its 
sequence. About 700 bp of 5' flanking sequence has been shown to 
contain a series of sites that could serve as binding sites for 
trans-acting tissue-specific/regulatory factors. These are the 
Nuclear Factor 1 (NFl) sites, BS6 (4 copies) and BS2 (5 copies). 
Multiple copies of the enhancer core sequence BS6(4), BS2(3), the 
glucocorticoid response element (3 copies in each) and the 
metallothionein gene metal responsive element BS6(3), BS2(5) are 
also found. However, only the glucocorticoid regulatory element 
occurs at a frequency significantly different from random 
expectation (Ghazal, 1986). One of the putative metal response 
elements lies within a 25 nucleotide palindrome present in BS6 but 
not in BS2 genes. The palindrome exhibits some homology with the 
metallothjonein metal response palindrome (Figure 4C). Sequence 
analysis indicates that Mup genes have an Ap2 binding site 
sequence at about -500bp with a match of consensus of 7 out of 8 
nucleotides (Held et al., 1987). 
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To determine whether the BS2 promoter is able to initiate 
faithful transcription in vivo, standard reverse genetic 
techniques were implemented. 
Mup expression in cell lines. 
Mup genes are expressed primarily in the liver (Clissold & 
Bishop, 1982). Liver tissue is appropriate for studying the 
expression of differentiated function because it is composed 
predominantly of a single type of differentiated cell, the 
hepatocyte, and hepatocytes express a large number of well 
characterised proteins including transferrin, albumin and alpha 
fetoprotein. Systems available for studying the regulation of liver-
specific genes include liver from intact animals, liver slices, 
primary hepatocytes in culture and cocultures of primary hepatocytes 
with epithelial cells. Primary hepatocytes in culture are useful for 
these studies because they can be derived from normal adult liver, 
and when maintained under the appropriate conditions they produce 
levels of albumin mP1A similar to that produced by the liver. The 
disadvantage of primary hepatocytes is that unlike a cell line they 
do not replicate, making it difficult to readily obtain large 
quantities of cells. Cultures of differentiated primary hepatocytes 
also require the use of collagen or a matrix. Cocultivation with 
epithelial cells eliminates this problem but results can be 
complicated by the effects caused by the presence of the second cell 
type. Work has been carried out on the expression of Mup genes in 
hepatocytes (Clayton & Darnell, 1983; Spiegelberg & Bishop, 1987). 
When hepatocytes are plated the expression of Mup genes is rapidly 
switched off. This results in a dramatic fall in the level of Mup 
mRNA to virtually zero in about 4 days. During the same time period 
the level of transferrin mRNA doubles and alphafeto protein mRNA 
appears denovo. This shows that the integrity of the cells is 
maintained in culture during changes in expression which seem to 
mimic liver regeneration. "Run-on" experiments with isolated nuclei 
showed that the fall in the level of Mup mPNA could be explained 
by a decrease in the rate of RNA transcription from the Mup genes. 
It seems possible that these changes might not occur under different 
culture conditions. Spiegelberg & Bishop (1987) show that growth 
hormone, thyroxine and insulin all retard the the rate of decay of 
Mup transcription in cultured hepatocytes. Growth hormone and 
thyroxine also show a synergistic effect. 
Liver derived cell lines, including hepatoma cells and immortalised 
hepatocytes, have been used to study the expression of liver 
specific proteins. Hepatoma cell lines replicate continuously in 
culture without a matrix. Although hepatoma cell lines are derived 
from tumour and not normal tissue, the H411EC3 rat hepatoma (Ohanian 
et al., 1969) and the HepG2 human hepatoma (Knowles et al., 
1980) cell lines have been used succesfully in studying liver 
specific proteins. One limitation to the use of many hepatoma cell 
lines is that they are grown in serum which contains undefined 
substances that can alter gene expression. In general, a 
disadvantage of most hepatoma cell lines is that they express liver 
specific genes at much lower levels than those expressed by the 
intact liver. A further complication is the fact that different 
immortalised cell lines from a given tissue show considerable 
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variability in their phenotypic expression. Recently workers have 
derived a series of SV40 immortalised rat hepatocyte cell lines 
which produce albumin and albumin mRNA at levels found in the normal 
liver and freshly isolated hepatocytes (Woodworth & Isom, 1987). It 
is not known whether these cell lines expressc42u-globulin. 
Mup genes can be expressed in BHX fibroblasts when coupled to an 
SV40 enhancer. 
Held et al., (1987) transfected mouse L cells with Mup genomic 
clones but only observed a low level of expression. High level Mup 
gene expression may well require multiple tissue and hormone 
specific factors which are not present in L cells. Ideally the study 
of Mup expression would have been carried out in a mouse liver 
cell line which expresses the endogenous Mup genes. To date there 
are no such lines available. Instead attention was focused on the 
fact that although a large number of promoters work very weakly or 
not at all in some cell lines, their activity can be forced to 
higher levels by linking enhancer sequences to them in cis. 
Examples are the - globin (Banerji et al., 1981), conalbumin 
(Wasylk et al., 1983) and lysozyme promoters (Renkawitz et al., 
1984). The SV40 enhancer, being one of the strongest enhancers and 
active in many cell types, is often chosen for this purpose. It was 
found that heterologous coding sequences linked to the promoter of 
the group 1 Mup gene BS6, could be expressed in Baby Hamster 
Kidney (BHK) fibroblast cells when coupled to the SV40 enhancer, but 
not in its absence (Bishop, unpublished). This establishes that the 
BS6 promoter can be activated but reveals nothing about its 
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behaviour in the liver. Its inability to function as a promoter on 
its own in fibroblasts is of course consistent with the lack of 
expression of endogenous mouse Mup genes in these cells. Si 
nuclease and primer extension assays show that RNA messages were 
being faithfully initiated at the Mup CAP site (Ghazal, 1986). The 
BS6 promoter showed a unique property in that it abolished the 
promoter activity of the upstream SV40 promoter, although the latter 
is closer to the SV40 enhancer (Ghazal, 1986). 
Constructs were made to test the fidelity of the BS2 promoter in BHK 
fibroblasts. The basic components of the plasmid were an SV40 
enhancer and early promoter and 2.2 kb of 5' flanking sequence from 
the group 2 Mup gene BS2, linked to the coding region for the 
Herpes simplex virus thymidine kinase type 1 gene. To facilitate the 
rescue of the hybrid gene from the genomic DNA of transgenic mice 
the construct contains the bacterial amber suppressor tRNA gene 
SupF (Goldfarb et al., 1982). 
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Viral thymidine kinase and bacterial neomycin resistance genes 
in transfection systems. 
Thymidine kinase is an enzyme which catalyses the phosphorylation of 
thymidine to thymidine monophosphate in the salvage pathway of 
pyrimidine synthesis. Herpes simplex virus encodes a novel thymidine 
kinase. The transcribed portion of the gene is approximately 1300 
nucleotides in length and contains no intervening sequences (Wagner 
et al., 1981). There is an untranslated region of 107 nucleotides 
at the 5'end of the mRNA followed by an open reading frame of 1128 
nucleotides which codes for 376 amino acids. The promoter region of 
the Herpes simplex virus (HSV) thymidine kinase type 1 gene 
(HSVtk) has been extensively analysed and shown to contain the 
TATA and CCAAT consensus signals and two GC rich repeated sequences 
in the 105 bp upstream from the normal CAP site (McKnight & 
Kingsbury, 1982; McKnight & Tjian, 1986). See Figure 2B. The 
availability of this information enables the separation of the tk 
gene into its promoter and coding region fragments. This can be 
achieved by digesting the gene with Hincil or BglII, both of 
which cut once within the region corresponding to the 5' 
untranslated region of the mRNA. The 5' fragment can be used as a 
promoter for DNA sequences which lack a functional promoter, but 
which contain all the other necessary components for example the 
initiation codon. A deletion of the promoter region reduces the 
number of thymidine kinase proficient transfectants to 0.1-1% 
relative to an intact tk gene (McKnight & Gavis, 1980). The 
substitution of this region by exogenous DNA sequences has allowed 
the development of a suitable assay system for the identification 
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and analysis of eukaryotic control elements. The promoter deleted 
tk gene can be convieniently isolated in a 1759 bp BglII- 
BstEII fragment containing 57 bp of leader sequence (Wilkie et 
al., 1979). It is inactive in gene expression studies but can be 
reactivated by insertion of DNA sequences that contain cis-acting 
regulatory elements. The TK+  phenotype can be efficiently 
selected over a TK background by utilising growth conditions in 
which the pyrimidine salvage pathway enzyme, thymidine kinase, is 
necessary for survival (Littlefield, 1964). The growth medium HAT 
contains Hypoxanthine, Aminopterin and Thymidine. Aminopterin 
inhibits the de novo synthesis of dATP, dGTP and dTTP from 
dihydrofolate. Hypoxanthine is a substrate for the salvage pathway 
for dATP and dGTP and therefore allows these nucleotides to be 
synthesised. Thymidine is essential for the synthesis of TTP and is 
totally dependent on an active tk gene (Figure 5). It has been 
suggested from experiments which show an amplification of truncated, 
promoterless tk genes in HAT medium that the survival of a cell in 
HAT medium may involve some threshold level of expression (Roberts & 
Axel, 1982). Any cell which expresses a tk gene below that 
threshold will not survive. 
There exist cell lines deficient in TK with low rates of spontaneous 
reversion to the TK 
+
phenotype which can be used as recipients 
for example Baby Hamster Kidney (BHK) fibroblast cells (Macpherson & 
Stoker, 1962). Under appropriate conditions either the TK or 
TK phenotypes can be selected. TIC cells are resistant to 
the thymidine analogue BUdR. The tk gene is thus an ideal subject 




A diagram to show the biosynthetic pathways of dinucleotide 
triphosphates, dATP, dGTP, dTTP. 
HAT medium contains hypoxanthine, axninopterin and thymidine. 
Aminopterin blocks the endogenous synthetic pathway of dinucleotide 
triphosphates and the salvage pathway is stimulated. This requires 
hypoxathine and thymidine as substrates. A functional thymidine 
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well characterised viral protein of known function which is 
distinguishable from the cellular enzyme in immunogenicity, 
molecular weight, substrate specificity and electrophoretic 
mobility. The active HSVtk gene can be detected in extracts of 
transfected cells by measuring the conversion of radiolabelled 
thymidine to thymidine phosphates. Since the virus encoded enzyme 
has different substrate specificities and feedback control from the 
cellular enzyme, cell encoded activity can be selectively inhibited 
by the addition of 0.2mM TTP allowing only the assay of HSV-
thymidine kinase (HSVTK) (Jamieson & Subak-Sharpe, 1974). This 
property is utilised in the assays for tissue specific expression of 
the transgene in mice. 
HSV thymidine kinase is representative of a type of selectable gene 
which can only be introduced into cells which are mutant and lack 
its expression. Other selectable genes can be introduced into any 
cell. An example is the bacterial neomycin resistance gene (neo). 
This gene, because of its bacterial origin, is normally 
nonfunctional in mammalian cells. However, the addition of a 
mammalian promoter and poly A sequences permit its expression. The 
nec gene codes for an aminoglycoside modifying enzyme which 
inactivates the aminoglycoside antibiotic G418. Mammalian cells are 
not sensitive to this antibiotic. The development of a drug, G418, 
which is cleaved by the nec gene product and to which mammalian 
cells are sensitive, enables selection of an active neomycin gene. 
G418 is usually used at a concentration of 400ug/ml. At lower 
concentrations (lOOug/ml) there is a significant delay but the cells 
are eventually killed (Southern & Berg, 1982). 
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CHAPTER 6: MATERIALS AND METHODS. 
Tissue culture methods. 
The cells used in the experiments were baby hamster kidney 
fibroblasts which are deficient in thyrnidine kinase (BHKtk ). 
The parent line of these cells was derived from the kidneys of 5 
unsexed, one day old hamsters (Macpherson & Stoker, 1962). Cells 
were grown at 37°C in 5 % CO2 in Dulbeccos Modified Eagles 
Medium (DMEM) supplemented with 3.7gl 1sodiuxn hydrogen 
carbonate, 10% foetal calf serum (Gibco), penicillin (100u/ml) and 
streptomycin (iDOug/mi; Gibco). Culture vessels were purchased from 
NUNC. Cells were detached by trypsinisation with 0.25% trypsin, 
0.02% EDTA. 
DNA mediated gene transfer. 
Transformation experiments were carried out with exponentially 
growing recipient cells seeded 24 hours before the addition of donor 
DNA. The medium was not changed before the addition of the DNA 
solution. Transfections were carried out based on the calcium 
phosphate technique (Graham & van der Eb, 1973) described in the 
protocol by Spandidos and Wilkie (1984) with the modifications noted 
below. The DNA/calcium phosphate co-precipitate was maintained on 
the cells for 12 hours after which a pre-selection expression time 
in non-selective medium was established to give maximum expression 
of the transfected gene. The expression is maximal with pre- 
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selection expression periods of 36 hours for the BHKtk cells 
used. After this period cells were either harvested for transient 
activity, or selected for HSVTK expression in DMEM +10% HAT (Gibco) 
(Hypoxathine, Aminopterin, Thymidine; Littlefield, 1964) or neo 
expression in DMEN + G418 (400 ugmll). 
Long term stable expression. The DNA/calcium phosphate co-
precipitate was added to the culture medium at a ratio of 0.7mls 
coprecipitate (containing 5ug of uncut Form 1 DNA) to 2 x105  
cells, in 5mls of medium in a 4.5cm diameter dish • After 12 hours 
the medium was replaced with fresh non-selective medium for a 
further 36 hours, when selective medium containing HAT was applied. 
The medium was changed every 3 days for up to 14 days before the 
colonies were counted. 
Transient Expression. The DNA/calcium phosphate co-precipitate was 
added to the culture medium at a ratio of 0-. 6mls coprecipitate 
(containing 15ug of DNA) to 8 x 10 cells in 10 mis of medium in 
a 9cm diameter dish. After 12 hours absorption and 36 hours pre-
selection expression the cells were harvested and assayed for HSV 
thymidine kinase as described. Carrier DNA was arnittéd  from the 
transfections. Replica plates were carried out for each of the 
transfected recombinants. 
Herpes simplex virus thymidine kinase assay. 
The cells were harvested by washing twice in ice cold Phosphate 
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Buffered Saline (PBS) before they were scraped off into 5mls PBS and 
pelleted by centrifugation. A further washing with 5mls PBS and 
cent'Ifugation followed, before the cells were taken up in 200ul of 
chilled sonication buffer containing 10mM potassium chloride, 2mM 
magnesium chloride, 10mM Tris, 1mM ATP, 10mM sodium flouride and 
50mM arninocaproic acid pH 7.4 (Brinster et al., 1981). The cells 
were pelleted by cent'Ifugation (10' at 15000g) after being lysed by 
sonication at 4°C for 5 hours. The enzyme assay is described by 
Spandidos and Wilkie (1984). The unit of thymidine kinase activity 
is the amount of enzyme which catalyses the formation of lpmol of 
TMP in 1 minute. Protein was determined the Bradford method 
(Bradford, 1976) for specific activity measurements. A 15u1 aliquot 
of cell supernatant was added to 75ul of reaction mixture containing 
10mM magnesium chloride, 150mM Tris (pH 7.5), 10mM ATP, 25mM sodium 
fluoride, 10mM -mercaptoethanol and 15uCi of tritiated thymidine 
3H-TMP (90 Ci/mmol; xnershain). The mixture was incubated at 
37°c. The 3H-TMP produced was measured by spotting 25ul of 
mix onto DE-81 paper (Whatman) discs at time intervals 30, 60 and 
120 minutes. The discs were washed 4 times, 10 minutes each, in 10mM 
Tris (pH 7.5) with shaking and dried under vacuum at 80°C. The 
radioactivity on the filters was determined by liquid scintillation 
counting (scintillant was 5g/l PPO, 0.3g/l dimethyl POPOP in 
toluene). The cell extracts were stored at -70°C. The assaying 
of thymidine kinase in mouse tissues was as described but with the 
following refinements. Tissues were dissected and immediately washed 
in ice cold PBS before being homogenised in sonication mix buffer. 
The reaction mix differed from that described by the addition of 
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0.4mM TTP which inhibited endogenous thymidine kinase by feedback 
control (Jamieson & Subak-Sharp, 1974). 
Northern blots and DNA probes. 
RNA was prepared from the cells by the guanidinium thiocyanate 
method (Chirgwin et al., 1979). After a PBS wash, 4mls of solution 
containing 4M guanidinium thiocyanate, 0.5% w/v sodium N-lauryl 
sarcosinate, 25mM sodium citrate, 0.1% w/v Sigma antifoam A and 0.1M 
-mercaptoethanol, were added to a 9cm diameter plate containing 8 x 
1O5 cells. The resulting solution was layered over 1.2mls of 
5.7M caesium chloride buffered with 25mM sodium acetate (pH 5) and 
centrifuged at 36K, 20°C for 12 hours. The pelleted RNA was 
resuspended in imi of 7.5M guanidine hydrochloride, 25mM sodium 
citrate (pH 7), 5mM DTT and precipitated twice, once with 0.025 
volumes of 1M acetic acid, 0.5 volumes of ethanol and once with 2mls 
double distilled water, 0.1 volumes of 2M sodium acetate and 2 
volumes of ethanol. The RNA was finally taken up in double distilled 
water for experimental use. Northern blot analysis was carried out 
as described by Church and Gilbert (1984) using Hybond-N (Arnersham) 
nylon membrane and randomly primed probe with a specific activity of 
approximately 10 cpm per ug (Feinberg & Vogelstein, 1984). The 
tk probe was an 840 bp PstI fragment of pTK1 which overlaps 
806 bp between the point of fusion with the Mup promoter region 
and a PstI site internal to the TK coding region (Wagner et al., 
1981; McKnight et al., 1981). Marker DNA was prepared by run-off 
transcription of plasmid DNA containing a 1922 bp EC0RI-PvuII 
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fragment of pTK1 inserted into the polylinker region of pT7.1, 10 bp 
downstream of the T7 RNA polymerase initiation site. The plasmid was 
digested separately with AccI, BanI, Smal and NarI and each 
fragment was transcribed in the presence of low specific activity 
3H-UTP to generate fragments 434, 1009, 1306 and 1816 
nucleotides long. After recovery these were combined to make a set 
of markers. 
Polyadenylated RNA was separated from the Poly A fraction by 
passing the RNA over an oligo dT column. 
Transgenic animals and lines. 
(C57BL/6J X CBA) F1 females were superovulated and DNA 
microinjected as described in Al Shawi et al., (1988). Transgenic 
mice were identified by Southern blot analysis of tail DNA. 
Transgenic females were mated to (C57BL/6J X CBA) F1 males. Copy 
number estimates of the transfected plasmid in cell lines were 
determined by Southern blot analysis. 
Primer extension assay. 
In a siliconised microcentrifuge tube were mixed 18 fmoles of DNA 
primer, end labelled with T4 polynucleotide kinase, with 1.8 fmoles 
of TK poly A RNA, 2ul of 5x Hybridisation buffer (2M NaCl, 50mM 
PIPES pH 6.4, and water to a final volume of lOul. The mixture was 
taken up and sealed in a glass capillary tube. The capillaries were 
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heated at 700C for 3 mins and left at the annealing temperature 
of 60°C for 6 hours. After annealing the contents were expelled 
into 90 ul of extension reaction buffer (50mM Tris-Hcl pH 7.6, 10mM 
DTT, 6mM MgCl2, 0.5mM each of dATP, dCTP, dGTP, dTTP, 2.5 ug of 
actinomycin D and 15 units of AMV reverse transcriptase (Pharmacia 
FPLC pure). The extension reaction was carried out at 42°C for 
60 minutes and terminated by the addition of 5ug of E.Coli tRNA, 0.1 
volumes of 3M sodium acetate pH 7.0 and 2.5 volumes of ice cold 
ethanol. After an overnight precipitation at -20°C the samples 
were centrifuged at 12000g for 10 minutes, rinsed with 95% ethanol 
and spun for a further 5 minutes. The pellet was dried under vacuum 
for 10 minutes and loaded on to a 6% urea acrylamide denaturing gel 
in 3u1 of ix TBE and 3u1 of formainide dye mix. 
Si nuclease protection assay. 
In a siliconised centrifuge tube were mixed 20 fmoles of the Si 
probe and 2.3 fmoles of TK poly A+ RNA in SOul of water. This 
was precipitated overnight at -20°C by the addition of 0.1 
volumes of 3M sodium acetate pH 7.0 and 2.5 volumes of ethanol. 
After centrifugation at 12000g for 10 minutes the resulting pellet 
was washed with 70% ethanol, lyophilised, and resuspended in lOul of 
80% formnamide, 0.4M NaCl, 1mM EDTA and 50mM PIPES pH6.4. The 
solution was drawn up into a 20u1 siliconised glass capillary, 
sealed, and immersed into a 75°C water bath for 5 minutes to 
denature the DNA. These were then transferred immediately to the 
hybridisation temperature of 60°C and left for 6 hours. The 
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reactions were snap frozen in dry ice and the contents expelled into 
190u1 of ice cold Si mix containing 0.28M NaCl, 50mM sodium acetate, 
4.5mM ZnSO4, 2ug of denatured salmon sperm DNA and Si nuclease at 
750 units /ml (Boehringer Mannheim). The tubes were incubated at 
37°C for 45 minutes and the reaction terminated by the addition 
of 5ug of E.Colj tRNA, 0.1 volumes of 3M sodium acetate pH7.0 and 
2.5 volumes of ethanol. The samples were then treated as described 
for the primer extension products. 
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CHAPTER 7: CONSTRUCTION OF HYBRID GENES. 
Thymidine kinase constructs 
Plasmids are based on psv2gpt (Mulligan & Berg, 1980) retaining the 
341 bp PvuII-HindIII SV40 enhancer and early promoter region and 
the 2293 bp PvuII-EcoRI portion of pBR322, containing the origin 
of replication and the -lactamase gene for selection of the 
recombinant. Plasmids pSVBS2tkSupF and pSVBS2Ne0SupF were 
constructed by myself. In this thesis the letters pSV.. denote an 
SV40 early promoter and enhancer. To accentuate this the letters EP 
may be added to give pSVEP. Both nomenclatures refer to the same 
plasmid. 
pSVBS2tkSupF 
Between the Hindill site and the EcoRI site the following 
fragments were inserted (a * denotes that the site was blunt ended 
with DNA Polymerase I and ligated with T4 DNA Ligase). Seven 
nucleotides of polylinker M13tg131, HindIII_*BamHI (TGGGATC) 
(Kieney et al., 1983), a 2283 bp *EcoRI_S96I fragment of 
Mup gene BS2 (Clark et al., 1982; 1985) containing the TATA box 
and CAP site (see Figures 6 & 7), a ten nucleotide fragment *XbaI... 
*BHI from polylinker M13mp19 (CTAGAGGATC) (Yanisch et al., 
1985) and a 1759 bp *BglII_*BStEII fragment of Herpes simplex 
virus thymidine kinase type 1 gene (HSVtk) from plasmid pTK1 
(Wilkie et al., 1979). The plasmid pSVBS2tkSupF was completed 
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with a 10 bp *SalI_*BamHI fragment of the M13tg130 polylinker 
(TCGACGGATC), a 400 bpAlul-XbaI fragment of PIVX containing the 
E.Coli Sup-F gene (Seed, 1983) and a 36 bp XbaI-EcoRI fragment 
of the M13tg130 polylinker (Figures 6 & 8). Restriction analysis of 
the resultant recombinant plasmid is shown in Figure 9. The major 
components are delineated. The coordinates of the restriction sites 
can be compared to the sites used in the cloning strategy of the 
construct (Figure 8). 
pSVBS6tkSupF 
Between the Hindlil and EcoRI sites of pSV2gpt the following 
fragments were inserted: an approximately 2200 bp HindIII-Sau3A 
fragment of Mup gene BS6 (Clark et al., 1982) containing the 
TATA box and CAP site (see Figures 6 & 7), seven nucleotides of 
polylinker (GATCCCC),and a 1759 bp *BglII_4EII fragment of 
HSVtk from plasmid pTK1 (Wilkie et al., 1979). The plasmid 
pSVBS6tkSupF was completed with a 10 bp *SalI_ *BamHI fragment 
of PIVX and a 36 bp XbaI-EcoRI fragment of M13tg130 polylinker. 
pSVtkSupF and pOtk 
Plasmids were constructed from the plasmid pSV2S3BS6tk (Bishop, 
unpublished). 
pSVtksupF retains the pBR322 and SV40 sequences from pSVgpt. The 
1759 bp *Bg1II_*+EII fragment from pTK1 is linked to the 




Structures of pSV2gpt and derivative plasmids: pSVEPtkSupF, 
pSVBS6tkSupF, pSVBS2tkSupF, and pOtk. 
The broken lines indicate 2293 bp of pBR322 vector DNA and the 
stippled regions represent the 341 bp SV40 enhancer and early 
promoter region. Major urinary protein (Mup) coding sequences, 
approximately 2 kb of BS6 or BS2, are shown as shaded boxes. The 
thymidine kinase (TK) coding region (1759 bp) is shown as a hatched 
box and the bacterial SupF gene (400 bp) is represented by a 
cross hatched box. In pSV2gpt the clear region indicates the E.Coli 
gpt gene. The sequences of the intervening polylinker sequences are 
shown. The maps are not drawn to scale. The arrow indicates the 
direction of transcription. 
E, EcoRl. H, Rindlil. S, Sau3A. P, PvuII. X, XbaI. B, 
BglII. 


























































Schematic representation of constructs pSVBS6tkSupF and 
pSVBS2tkSupF. 
The four major components of the plasmid constructs are shown. These 
include: 
the entire Simian virus 40 (SV40) transcriptional control 
fragment containing the SV40 enhancer, early promoter and TATA 
sequence. 
A fragment of major urinary protein (Mup) gene BS6 or BS2, 
containing TATA and CAP consensus, with approximately 2 kb of 5' 
flanking region. 
The Herpes simplex virus thymidine kinase type 1 gene as a 
reporter. 
The bacterial SupF gene for the isolation of recombinant 
clones. 
The numbers refer to the length in base pairs of each particular 
segment. The DNA sequence at the Mup/thymidine kinase junctions 
are shown. The intervening polylinker sequences are underlined 
). The Mup TATA boxes are shown () and the putative 
transcription initiation sites are indicated (arrow). 
The sequences shown in the figure for plasmid pSVBS6tkSupF are 
predicted rather than having being determined from DNA sequencing 
work that I have undertaken. The portion of the sequence of 
pSVBS2tkSUPF detailed, has been verified by sequencing of the Si 
probe which spans this region (See Chapter 9). 
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Figure 8. 
Cloning strategy of the plasmid construct pSVBS2tkSupF. 
The shaded areas represent the Mup gene BS2 sequences which were 
cloned in two separate stages into the Hindill and BglII sites 
of pSV2tkS2BtkSupF. The single lines represent polylinker sequences. 
The length of each segment in base pairs is indicated. The map is 
not drawn to scale. 
E, EcoRI. P, PvuII. H, Hindlil. B, BglII. S, Sail. Su, 
Sau96. Bm, BarnHI. 
Figure 9. 
Restriction analysis of the plasmid pSVBS2tkSupF. 
The diagram shows the coordinates of major restriction enzyme sites 
which delineate the separate fractions of the construct. The total 
length of the plasmid is 7146 base pairs. 
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length of M13 polylinker containing the PstI and Sail 
restriction sites and ending with a *BamHI site (Figure 6). This 
construct is completed as pSVBS6tkSupF. 
pOtk is constccted from the plasmid pSVtk. This is linearized with 
a PvuII partial digest, cut with Hindlil, blunted with DNA 
polymerase 1 and recircularized to give pOtk. The plasmid does not 
contain PIVX SupF sequences. It is completed with a 57 bp *SalI_ 
EcoRI fragment from M13 polylinker (Figure 6). 
Neomycin Constructs 
Plasmids are based on pSV2gpt (Mulligan & Berg, 1980) retaining the 
341 bp PvuII-HindIII SV40 enhancer and early promoter region and 
the 2293 bp PvuII-EcoRI portion of pBR322 containing the origin 
of replication and the -lactamase gene. 
pSV2 tekS2BSupF=B 1 
Between the EcoRI sites and Hindlil sites the following 
fragments are inserted: twenty one nucleotides of polylinker Mp9 
HindIII-Sau3A, a 268 bp Sau3A-BamHI fragment of Mup gene 
BS6, (Clark et al., 1985), a 458 bp BamHI-BglII fragment of 
from the plasmid pTK1 (Wilkie et al., 1979) containing the HSVtk 
promoter, a 1003 bp fragment BglII-SmaI fragment of the neo 
gene coding for resistance to the antibiotic Neomycin, from plasmid 
pSV2neo (Southern & Berg, 1982) and a 595 bp fragment SinaI- 
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*4EII, from pTK1 containing the HSVtk polyadenylation signals. 
The plasmid was completed with a 10 bp *lI_*BHI  fragment of 
the M13tg130 polylinker, a 400 bp AluI-XbaI fragment of PIVX 
containing the E.Coli Sup-F gene and a 36 bp XbaI- EcoRI 
fragment of M13tg130 polylinker. 
pSVBS2Ne0SupF 
This is constructed from Bi by substitution of the 1026 bp 
Hindill- BglII fragment, containing the Mup BS6 Sau3AI 
fragment and the HSVtk promoter region, with a 2303 bp Hindill-
*JnHI fragment from pSVBS2tkSupF. This contains 10 bp of linker 
sequence, 2283 bp of Mup BS2 sequence and 10 bp of M13mp19 linker 
(see Tk constructs). 
pSVBS6Ne0SupF 
This is constructed from Bi as for pSVBS2Ne0SupF. Between the 
Hindill and *BglII sites left after removal of the 1026 bp 
fragment, the following fragments were inserted: a 1820 bp Hindlil-
BamHI fragment from BS6-2 and a 323 bp BamHI-Sau3A fragment 
from BS6-2-4 (Clark et al., 1982). Three base pairs of linker 
Sau3A_*SmaI complete the sequence. 
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Construction of the plasmid pSVBS2tkSupF. 
In the previous paragraphs I describe the linear order of DNA 
fragments and sequences which make up each of the DNA constructs. In 
this section I will describe in detail how the plasmid 
pSVBS2tkSupF was constructed. This text refers specifically to 
Figure 8. The starting plasmid was pSV2tkS2BSupF constructed by M. 
Richardson. 
Plasmid pSV2tkS2BSupF contains: 
a 2293 bp EcoRI-PvuII portion of pBR322. 
a 341 bp PvuII-HindIII portion of SV40 DNA containing the 
SV40 enhancer and early promoter region. 
a 1026 bp HindIII-BglII DNA fragment. This fragment 
contains the MUP BS6 promoter region identified by two Sau3A sites 
(S2) and extending to aBamHI site (B), 3' to the CAP site (Clark 
et al., 1985b). See page 55. In addition this fragment contains 
the HSVtk promoter region delineated by a BamHI-BglII fragment 
(Wilkie et al., 1979). 
a 1759 bp BglII_*BStEII DNA fragment containing the HSVtk 
gene and v) the bacterial SupF gene (see page 53). 
In the construction of pSVBS2tkSupF I have substituted the 1026 
bp HindIII-BglII DNA fragment of pSV2tkS2BSupF for approximately 
2.2 kb of BS2 sequence containing the BS2 TATA box, potential CAP 
site and 5' flanking region. In all other respects pSVBS2tkSupF is 
identical to pSV2tkS2BSupF. 
The cloning of the BS2 fragment was achieved in two stages (Figure 
8). A * denotes that the site was blunt ended with DNA polymerase I 
and ligated with T4 DNA ligase. 
1) The majority of the BS2 sequence present in a 2171 bp *ERI_ 
Sail DNA fragment (Clark et al., 1982) was cloned into M13tg130 
by utilising the Sail and *BamHI sites present in the polylinker 
of the vector. 2) A second 112 bpgail_*Sau961 DNA fragment 
contains the BS2 TATA box and potential CAP site. This fragment was 
cloned into the vector PUC19 (mp19) by utilising the Sail and 
*XbaI sites present in the polylinker sequence. 
The larger BS2 fragment was isolated from M13tg130 in a Hindill-
Sail fragment. This was inserted 5' to the BS2 SalI_*Sau961 
fragment by utilising the Hindill site present in the PUC19 
polylinker (Figure 8). The complete BS2 5' region can then be 
isolated from PUC19 in a 2300 bp HirldIII_*BamHI DNA fragment. 
This fragment was used to substitute the 1026 bp Mmdiii- *BgiII 
DNA fragment of pSV2tkS2BSupF. The resultant *5ItHI/*BglII 
fusion at the 3' end of the fragment generates a Sau3A site 
(Figure 9; coordinate 4935). The sequence of the construct across 
this junction was verified by sequencing of the Si probe (See 
Chapter 9 and Figure 14). The sequence for pSVBS6tkSupF is a 
predicted sequence and has not been derived from sequencing work 
that I have undertaken. 
CHAPTER 8: TRANSIENT AND STABLE TRANSFECTION ASSAYS. 
Introduction. 
On initial transfection of a gene into a cell population, only a 
small proportion of the cells are found to have stably integrated 
and expressed the gene. The integration of transfected DNA is not 
essential for its expression. In certain cell lines a relatively 
high proportion of cells express the transfected gene up to 72 hours 
post transfection. After this time the activity decreases (Pellicer 
et al., 1980). This has been termed transient expression. 
Transient expression systems assay the expression of transfected DNA 
which has not integrated into the recipient chromosome. They have 
proved to be an efficient and accurate way to delineate proximal and 
distal regulatory sequences responsible for correct initiation of 
RNA transcription (Walker et al., 1983; Charney et al., 1985; 
Elkareh et al., 1985; Grosschedl & Baltimore, 1985). Since the DNA 
is not incorporated into the genome the influences of cis-acting 
sequences at the site of integration are avoided. These may act by 
silencing or enhancing gene expression. The time of maximum 
transient expression varies for the type of gene being transfected 
and the recipient cell line used. 
The expression of a selectable transfected gene which has integrated 
into the recipient genome can be analysed by counting the number of 
transformants which survive in a selective medium and develop into 
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colonies. The number of surviving colonies which derive from a 
population of cells can be expressed as a transformation efficiency. 
Banerji et al., (1981) show that the fidelity of transcription in 
transient assays is as good as that obtained with stable 
transformants. The performance of transient expression systems can 
be enhanced by utilising DNA vectors that include portions of the 
SV40 geriome, containing the SV40 replicative origin and early 
promoter region. These components can facilitate increased 
expression by replication and consequent copy number amplification. 
The coupling of an enhancer for example SV40 to a gene can promote 
transcription (Banerji et al., 1981; DeVilliers & Schaffner, 
1981). This depends on the combination of enhancer, promoter and 
recipient cell. 
When introduced into BHKtk cells, sequences from the Mup 
gene BS6 promoter do not initiate transcription unless linked to an 
SV40 enhancer (Bishop, unpublished). For this reason a 8V40 enhancer 
is also present in the analysis of the BS2 promoter. 
The ability of various reconstructed thymidine kinase genes to 
express RNA and active enzyme was tested using two distinct 
techniques. Transient levels of tk specific RNA and thymidine 
kinase enzyme (TK) activity induced in transfected BHKtk 
cells 48 hours post transfection was measured. In addition the 
ability of recombinant plasmids to transform BHKtk cells to a 
stable TK+ phenotype in selective HAT growth medium was 
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determined. In this case the levels of tk mRNA and thymidine 
kinase enzyme activity in individual clones was measured. 
Transient Expression Assay. 
Time Course. 
Hamster BHKtk cells were transfected with the plasmids 
pSVtkSupF, pSVBS6tkSupF, pSVBS2tkSupF and pOtk. Cultures were 
harvested at various times post transfection and used to determine 
TK enzyme levels. The optimum time for expression was found to be 36 
hours for the BHKtk cells used (Figure 10). 
The effects of different Mup gene transcriptional control 
sequences. 
The effects of different exogenous transcriptional control 
sequences on Herpes simplex virus thymidine kinase gene expression 
are shown in Table 1. BHKtk cells were transfected with the 
plasmids and TK enzyme activity was measured. 
Transient HSV thymidine kinase levels. 
Thymidine kinase assays reveal a low level of activity for 
pSVBS6tkSupF which is significantly different (P 0.055) from the 
value obtained with the plasmid pSVBS2tkSupF (Table 1B). The 
amount of enzyme produced in the presence of the BS6 promoter is 




Transient expression of the HSVtk gene in hamster cells. Time 
course. 
The graph shows the transient HSVTK enzyme activity in lysates of 
BHKtk cells transfected with various recombinant plasmids 
containing the Herpes simplex virus thymidine kinase type 1 gene. 
The plasmids pSVEPtkSupF, pSVBS6tkSupF and pSVBS2tkSupF were 
transfected as described in "Materials & Methods" using 5ug of DNA 
per 2x105 cells. The DNA-calcium phosphate coprecipitate was 
removed from the cells after 12 hours and the medium replaced with 
fresh non-selective medium. The cells were harvested and assayed for 
HSVTK activity at the time intervals shown. 
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Northern blot analysis of transiently expressed tk specific 
mRNA. 
Thirty-six hrs post transfection, RNA was prepared from cell cultures 
transfected with the plasmids (A) pSVeptkSupF, (B) pSVBS6tkSupF, (C) 
pSVBS2tkSupF. 25ug of each was fractionated on a 1.8% agarose-
formaldehyde gel, blotted onto a Hybond-N membrane and probed with a 
840 bp PstI fragment from pTK1. Marker tracts are transferrin 
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of the tk sequence is under the control of the SV40 early promoter 
(Table 1A). The transient activity of the plasmid pSVBS2tkSupF 
does not differ significantly from the background, pOtk, levels when 
the t-test for paired comparisons is applied (Table 1B). The low 
level transient expression of HSVTK from the BS2 promoter could be 
indicative of a non functional promoter or a very weak level of 
expression which is undetectable in the assay system. 
Transient HSV thymidine kinase levels. 
Total mRNA was extracted from duplicate plates and probed with a 840 
bp HSVtk specific DNA fragment (PstI-PstI; see Materials & 
Methods). Figure 11 shows the transient levels of tk specific RNA 
from cells transfected with the different plasmids. The messenger 
RNA produced in cells transfected with the plasmid pSVtksupF is 
approximately 1.3 kb long. This is consistent with transcription 
initiating at the SV40 early promoter CAP site and terminating at 
the thymidine kinase polyadenylation signal. No tk mRNA of a size 
consistent with initiation at the Mup CAP site is detectable in 
the transient samples for cells transfected with pSVBS6tkSupF or 
pSVBS2tkSupF. The lack of any transient HSVTK activity or tk-
specific RNA in cells transfected with the plasmid pOtk is 
consistent with the lack of a promoter in this construct. 
Taken together the data in Figure 11 and Table 1 show that in these 
experiments the most sensitive method for measuring promoter 
activity in transient expression is to quantify the amount of 
M. 
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'rh1 a 1A. 
A table to show the transient expression of HSV thymidine kinase 
in BHKtk cells transfected with plasmids containing Mup gene 
transcriptional control elements linked to the HSVtk gene. 
# Donor DNA (15ug) was added to recipient cells as a calcium 
phosphate coprecipitate in the absence of carrier as described in 
Materials & Methods. Fresh medium was added 12 hours later and 
incubation continued at 370C, 5% CO2 for a further 36 hours 
after which the cells were harvested. 
$ HSVTK activity was assayed as described in Materials & 
Methods. The relative enzyme activities for each construct are 
shown. HSVTK activity for psVEPtksupF transfected cells averaged 
llpmol/min/mg. All values are relative to this amount. 
Table lB. 
A table to show the significance of the differences in 
transient thymidine kinase values of different constructs in 
relation to one another. 
The method of paired comparisons was used to determine the values of 
t. 
TABLE 1 (A) 
Relative thyxnidine kinase activity 
over background 
Cell Line £Donor  DNA 1 2 3 4 5 Mean 
BHK.Tk pSVEPtkSUpF 100 100 100 100 100 100 
BHK.Tk pSVBS6tkSupF 2.85 4.9 5.9 6.9 6.6 5.43 
BHK.Tk pSVBS2tkSupF 1.8 4.5 4.7 2.9 4.4 3.66 
BHK.Tk pOtk 1.5 2.6 4.5 2.7 4.2 3.1 
TABLE 1 (B) 
t-test: paired comparisons 
Comparison *j value 
[N-i] 
DF P 
pSVBS6tksupF/psVBs2tksupp 2.8 4 0.055 
pSVBS6tkSUpF/pOtk 4.49 4 0.015 
PSVBS2tkSUPF/pOtk 1.67 4 >0.1 
PSVEPtkSUPF/POt)c 174.9 4 <0.001 
*Significance at the 5% level with 4 degrees of freedom requires 
a t value of 2.776. 
MM 
thymidine kinase enzyme present. 
Transformation of thymidine kinase deficient cells to a TK+ 
phenotype. 
A second way of measuring gene expression of tic plasmids is to 
measure the efficiency of biochemical transformation of cells from a 
TK to a TK+  phenotype. This was carried out by transfecting 
BHKtk cells and counting the number of TK+ transformed 
colonies after 14 days growth in selective HAT medium. The effects 
of different Mup transcriptional control sequences on tic gene 
activity are represented by a value of transformation efficiency 
(Table 2). Also shown are the results obtained for the 
transformation of BHKtk cells to a neomycin resistant 
phenotype. The constructs contained the same Nup control elements 
as did the tic plasmids, but differed in having the bacterial neo 
gene as a reporter. To allow for the variation in transformation 
efficiency, the results are expressed as a percentage of the number 
of colonies obtained with pSVtksupF for the tic constructs and 
plasmid Bi for the nec series. 
The results from the transformation assay are different from 
those observed for the transient expression assay. 
Expression of tic in cells transfected with pSVBS2tkSupF is shown 
by the survival of cells in HAT. The transformation efficiency of 




The number of colonies appearing in selective medium after the 
transfection of BHKtk cells with various constructs containing 
MUI' gene transcriptional control sequences linked to the HSVtk gene 
or the bacterial neomycin gene. 
# Donor DNA (5ug) was added to 2 x 10 cells as a calcium 
phosphate coprecipitate in the absence of carrier as described in 
the Materials & Methods. 
* The numbers of colonies represent the total colonies obtained 
with four duplicate transfections for each construct. Thymidine 
kiriase expressing colonies were selected in 10% HAT. Neomycin 
selection was carried out with the antibiotic G418 (400ug/ml). 
$ Relative efficiencies are expressed as a percentage of the 
number of colonies obtained with plasmid pSVtksupF for the tk series 
and Bi for the neo constructs. 
TABLE 2 










BHk tk None 0 0 0 0 0 
BHk tk pSVEPtkSupF 100 300 150 550 100 
BHk tk pSVBS6tkSupF 80 94 105 182 33 
BHk tic pSVBS2tkSupF 26 51 11 88 16 
BHk tk pOtk 2 6 0 8 1.45 
BHk tk None 0 0 0 0 
BHk tic pSV2tekS2BSupF 396 237 633 100 
(Bi) 
BHk tic pSVBS6neoSupF 297 93 390 67 
BHk tk pSVBS2neoSupF 162 34 196 31 
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pSVBS6tkSupF is 33% (Table 2). The BS6 sequences are twice as 
efficient as the BS2 sequences in transforming cells to a TK+ 
phenotype. When the neo gene was used as a reporter the same 
relationship between BS6 and BS2 sequences emerged. However, for a 
particular promoter sequence, the neo series of plasmids do tend to 
have a greater transformation efficiency (approximately 50%) than 
those harbouring a tk reporter sequence for example compare 
pSVBS6tkSupF and pSVBS6Ne0SupF (Table 2). This observed 
difference may be due to the ability of relative promoter strengths 
to be influenced by sequences in the genes transcribed from them. 
This observation has previously been described when different 
heterologous sequences are attached to the HSVtk promoter (Novak & 
Rothenberg, 1986; Koltunow et al., 1987). However, as the ratio of 
BS6 versus BS2 transformants are the same for each reporter sequence 
this is unlikely to be the case. Alternatively lower levels of neo 
expression may be enough to save cells from G418 compared with the 
tk levels needed to save the cells from HAT. 
There is a low but real transformation of cells from TK to a 
TK phenotype when transfected with the plasmid pOtk. As this 
plasmid lacks any natural promoter the observed activity is probably 
a result of the activation of the tic sequences by promoter 
elements at the site of integration. 
Gene expression in stably transformed cells. 
In order to examine the fidelity of transcription from the Mup BS6 
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and BS2 CAP sites several independent colonies from the 
transformation experiments were cloned and propagated in HAT medium. 
Cultures were harvested 14 days after isolation and used to 
determine levels of tk specific RNA and TK enzyme activity (Table 
3). The thymidine kinase probe will hybridise proportionately to the 
same amount of tk RNA in the total cellular RNA population as is 
present in the same intensity band of the marker. The tkRNA in a 
population of 25ug total cellular RNA gives the same signal as 
0.12ng of tkRNA synthesised from a 1816 bp EcoRl-Narl fragment 
placed downstream of a T7 promoter. For example in clone HS9 the 
amount of tk messenger RNA constitutes around 0.0005% of the total 
mPNA. 
The HSVTK activity in different clones is the same. 
Surprisingly, despite the large differences between different 
plasmids observed in the transient assay, the values of HSV 
thyniidine kinase activity in stably transfected clones of pSVtkSupF, 
pSVBSGtkSupF, pSVBS2tkSupF and pOtk are approximately the same. 
The amount of tk specific RNA does however vary widely between 
clones (Figures 12 & 13). The average value is 100 pmol/min/mg 
(Table 3). Thus, although markedly different levels of tk gene 
expression are measured by transient and transformation assay, long 
term culture in selective HAT medium may select cells in which the 




Thymidine kinase activities of individual clones transfected 
with different recombinant plasmids and the size of the tk specific 
mRNA produced from each clone. 
* The sizes of the transcripts were measured against thymidine 
kinase DNA transcribed from the T7 RNA polymerase initiation site. A 
discrepancy of 1mm in the measurement of the bands leads to an error 
of 50 base pairs in the size obtained 
HSVTK activity was assayed as described in Materials & Methods. 
TABLE 
Donor DNA 	Name of 	HSV Thymidine kinase *size of RNA trans- 
Clone Activity (pmol/min/mg) cript (base pairs) 
pSVEPtkSupF 	SV 2 	 52.8 	 1580 
SV 3 109 1550 
sv 4 	 98 	 1520 
pSVBS6tkSupF 	HS 1 120 1470 
HS 2 86 1470 + 	1180 
HS 5 250 1470 
HS 6 116 1470 + 930 
HS ND 1470 
pSVBS2tkSupF 	ES 1 188 ND 
ES 2 162 1390 
ES 3 118 1500 
ES 6 193 1700 + 	1250 
ES 8 ND 1260 
ES 9 147 <1816 
ES11 81 1340 
pOtk 	 Ot 1 202 1650 
Ot 3 165 1550 




Northern blot analysis of stably transfected clones. 
The figure shows a Northern blot hybridisation of tk specific RNA 
from clones stably transfected with plasmid constructs 
pSVBS2tkSupF, denoted clones ES2, ES3 etc, and construct 
pSVBS6tkSupF, denoted HS1, HS2 etc. 25 ug of total cellular RNA 
from each transformed cell line grown under selective conditions was 
fractionated on a 1.8% agarose formaldehyde gel, blotted onto Hybond-
N membranes and probed with a 840 bp Pstl fragment from pTK1. The 
marker tracts are the products of run-off transcription of a 1922 bp 
EcoRI-PvuII fragment from pTK1 inserted downstream from the T7 
RNA polymerase initiation site. The plasmid was digested separately 
with AccI, BanI, Smal and NarI and each fragment transcribed 
to give the fragment lengths indicated. 
pSVBS2tkSupF (ES) 	pSVBS6tkSupF (HS) 
6 2 3 9 11 1 2 6 9 CLONES 
__ 1816 - 	
I 	1306 
1009 
- 	 434 
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Figure 13. 
Northern blot analysis of stably transfected clones. 
The figure shows a Northern blot hybridisation of tic specific RNA 
from clones stably transfected with plasmid constructs pSVtkSupF, 
denoted clones SV2, SV3 etc, and construct pOtk, denoted Oti, 0t2 
etc. 25 ug of total cellular RNA from each transformed cell line 
grown under selective conditions was fractionated on a 1.8% agarose 
formaldehyde gel, blotted onto Hybond-N membranes and probed with a 
840 bp Pstl fragment from pTK1. The marker tracts are the products 
of run-off transcription of a 1922 bp EcoRI-PvuII fragment from 
pTK1 inserted downstream from the T7 RNA polymerase initiation site. 
The plasmid was digested separately with AccI, BanI, Smal and 
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RNA transcripts in clones transfected with pSVBS6tkSupF and 
pSVBS2tkSupF. 
Figures 12 & 13 show the sizes of tk-specific mRNA in clones of 
cells transfected with the different Mup/tk hydrid plasmids. The 
clones are titled ES if transfected with the plasmid pSVBS2tkSupF, 
and HS if transfected with the plasmid pSVBS6tkSupF. The letters 
ES denote the 2283 bp DNA fragment EcoRI-Sau961 from Mup gene 
BS2. The letters HS denote the 2200 bp HindIII-Sau3A DNA 
fragment from Mup gene BS6 (Figure 8). Clones transfected with the 
plasmids pSVtkSupF and pOtk are named SV and Ot respectively. Table 
3 gives the sizes of these transcripts as measured against RNA 
markers produced by run-on transcription of tk DNA fragments from 
the T7 RNA polymerase initiation site (Figure 14). An HSV-specific 
tk mRNA of approximately 1.5 kb was present at roughly the same 
concentration in a number of different clones transfected with 
pSVtkSupF (Figure 13). This strongly suggests that the tk gene is 
being transcribed from the SV40 promoter in the transformed cell 
lines SV2, SV3 and SV4, since the normal tk mRNA is known to have 
a size of 1.3 kb and initiation from the SV40 CAP site and 
termination at the normal tk polyadenylation site would result in 
an RNA of similar size. In cells transfected with pSVBS6tkSupF a 
band of 1.47 kb is present in all of the clones. In addition clones 
HS2 and HS6 express extra faint trancripts of length 1180 bp and 930 
bp respectively. These shorter messages could be due to initiation 
of tk mRNA from cryptic transcription start sites within the tk 
coding region or they may be initiating from the reverse strand of 
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tk. The observed 1.47 kb transcript is consistent with the 
initiation of the tk mRNA from the BS6 CAP site and termination at 
the tk polyadenylation signals. These results confirm previous 
studies with the plasmid pSVBS6tkSupF (Ghazal, 1986). Si mapping 
of the 5' ends of transcripts synthesised from the pSVBS6tkSupF 
construct transiently expressed in BHK cells, show that the SV40 
early promoter is used in pSVtksupF while the Mup promoter is 
preferentially used in pSVBS6tkSupF. The difference in size 
between the predicted message from the BS6 and SV40 early CAP sites 
and the observed lengths presumably reflects heterogeneity at the 3' 
end of the RNA. 
The sizes of transcripts in clones stably transformed with pOtk 
and pSVBS2tkSupF are very heterogeneous. 
There is considerable heterogeneity in the sizes of transcripts from 
individual clones obtained after transfection with pSVBS2tk SupF 
(Figure 12). The sizes range from 1.3 kb in clone ES11 to more than 
1.8 kb in clone ES9. Clone ES6 has two messages of 1700 and 1250 bp 
(Figure 12). None of these transcripts is consistent with the 
initiation of transcription at the BS2 CAP site and termination at 
the tk polyadenylation sequences. This would generate a 1.45 kb 
transcript. A similar variation in transcript size is observed in 
the stable transformants of pOtk (Figure 13). The size of these 
transcripts all exceed 1.4 kb. 
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Large, faintly hybridising tk specific transcripts are seen in 
transfected clones. 
Northern blot analysis of RNA reveals several large RNA species 
which hybridize weakly to the tk probe in some of the clones 
(Figure 12 & 13). In the cases of plasmids pSVBS6tkSupF and 
pSVBS2tkSupF these transcripts could be initiating from the SV40 
early promoter located 2 kb upstream. Probing of the Northerns with 
a 340 bp PvuII- Hindill fragment specific for the SV40 promoter 
and with the whole plasmid, minus the tk sequence, do not reveal 
cross hybridisation with any of these larger transcripts (data not 
shown). The extra long transcripts must therefore be transcribed 
from the chromosome or the reverse tk strand. The presence of the 
large transcripts in clones transfected with pSVtkSupF also suggest 
the latter case. Probing of the filters with a coding strand 
specific ribo-probe would be useful in resolving this problem. 
CONCLUSIONS. 
Promoter strength and transformation efficiency. 
It has been suggested that the initial, transient rate of expression 
of a gene is a major determining factor in the subsequent rate of 
biochemical transformation (Gorman et al., 1983; Lang et al., 
1983; Spandidos & Wilkie, 1983; Sodroski et al., 1984; Rutherford 
& Nienhuis, 1987). Thus, the proportion of cells which express the 
tic gene above the threshold for survival in HAT should depend on 
the relative expression of the gene and this is reflected in the 
levels of transiently expressed enzyme. This may not always be the 
case as the influence of sequences at the site of integration can 
overcome the lack of expression of a transfected gene for example 
pOtk. 
Promoter preference in plasmids transfected with pSVBS6tkSupF. 
The initiation of transcription at the CAP site of BS6 in preference 
to the Sv40 early promoter is unusual. Wasylyk et al., (1983) and 
de Villiers et al., (1982) show that in plasmids containing an 
SV40 enhancer and more than one natural or substitute promoter, 
proximal promoters are activated in preference to distal ones. 
Studies by Kadesh & Berg, (1986) lead to the same conclusion 
although another effect termed promoter occlusion may distort the 
magnitude of the apparent preference. Promoter occlusion causes 
reduced transcription at a downstream promoter if transcription is 
initiated at a nearby upstream promoter. 
The proximity of the SV40 promoter to the SV40 enhancer does not 
make it the preferential transcription initiation point. The sizes 
of the tk specific mPNAs produced in stably transfected clones of 
pSVBS6tkSupF are consistent with initiation of transcription in 
the region of the distal Mup promoter sequences, as shown by Ghazal 
(1986). This is in contrast to the results described above. It has 
been suggested that the Mup sequences may in some way down 
regulate the SV40 promoter (Ghazal, 1986). This may result from the 
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binding of a trans-acting factor to 5' Mup sequences which 
prevent the entry of DNA polymerase II to the template at the SV40 
CAP site. 
The Mup result may not be unique. Lang et al., (1983) showed that 
when an LTR enhancer is placed upstream of tk under the control of 
its own promoter, insertion of the LTR promoter between the enhancer 
and tk promoter had no effect in modulating gene expression. These 
results suggest that there is no absolute preference for the 
proximal promoter. Alternatively this observation might relate 
specifically to the tk sequence. 
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CHAPTER 9: Si NUCLEASE PROTECTION AND PRIMER EXTENSION 
ASSAYS. 
The Northern blot data shows that the tk specific RNAs from the 
clones stably transfected with the plasmid pSVBS2tkSupF are very 
heterogeneous. They are not of a size consistent with initiation 
from the BS2 CAP site and termination at the tk polyadenylation 
sequences. In order to map the transcription initiation start sites, 
Si nuclease and primer extension assays were implemented. 
Results. 
Si nuclease protection experiments. 
The Si probe was prepared by cloning the 1542 bp EcoRI-SphI 
fragment from pSVBS2tkSupF into the EcoRI and SphI sites of 
the M13tg131 polylinker. Synthesis of the second strand, 
complementary to the RNA, was initiated from the M13 universal 
priming site located 3' to the SphI site. The strand was uniformly 
labelled by the incorporation of alpha-dCTP P32 in the synthesis 
reaction. The resulting double stranded DNA was restricted with 
HpaI and Ec0RV and the resulting 1015 bp fragment isolated from 
a 0.8% agarose gel. Hybridisation of the probe with the RNA was 
effected in 80% formamide at 600C (see Materials & Methods). The 
probe is 59.6% GC rich. The 434 bp RNA transcribed from the EcoRI-
AccI fragment of pTKi placed 10 bp downstream of the T7 
transcription initiation site, served as an Si control. The observed 
290 bp protected fragment in the control reaction was in agreement 
with the expected result (see Figure 14 & 15 and Table 4A). The 
single stranded Si probe is not informative for transcripts which 
may be transcribed from the antisense strand of the tk gene. 
Poly A+ RNA from each of the four clones stably transfected with 
pSVBS2tkSupF were hybridised to the Si probe and exposed to Si 
nuclease. In each case the size of the protected fragment was 
different, as measured against an M13tg131 sequencing ladder (Figure 
15). RNA from clone ES2 resulted in a protected fragment of 124 bp 
(Table 4A). The doublet bands observed in clones ES3 (280 + 276 bp) 
and Es9 (293 + 291) are probably due to attack by Si nuclease on the 
DNA/RNA hybrid. Alternatively they might represent two transcripts 
which are very similar in size and derive from different copies of 
the integrated plasmid. Two widely separated fragments of 318 and 
150 bp are seen with RNA from clone ES6. This is in agreement with 
the fact that two major transcripts are seen on the Northern blot 
(Figure 12). The 5' termini of the RNA transcripts mapped in this 
way are shown in Figure 17. 
Primer extension experiments. 
To determine the start sites of transcription in these clones, 
primer extension assays were carried out. Two synthetic 
oligonucleotides were used. Primer A is 23 bp long and is 59.6% GC 
rich. It is complementary to RNA transcribed from the tk coding 




Restriction map and coordinates (bp) of the plasmid 
pSVBS2tkSupF showing its relationship to the probes used for Si 
protection and primer extension assays. The Si probe is a 1015 
bp Hpai- EcoRV DNA fragment. In the primer extension assays a 
22-mer oligonucleotide (coordinates 5020-5042) or a 20-mer 
oligonucleotide (5151- 5169) was used. The thymidine kinase coding 
region of the construct is shown by the cross hatched box. 
Restriction map of the 1992 bp EcoRI- PvuII from pTKi 
inserted into the polylinker region of pT71, 10 bp downstream of the 
T7 RNA polymerase initiation site. The plasmid was digested 
separately with Acci, Bani, Smal and Narl to generate the 
fragment lengths shown. RNA transcribed from the 434 bp species was 
used in the Si and primer extension assays as a control. 
Schematic enlargement of the restriction map of the 434 bp 
Acci- EcoRl fragment from pTK1 inserted 10 bp downstream of the 
T7 polymerase initiation site. The figure shows the extent of 
hybridisation of the Si probe to the RNA generated from this 
fragment. A 290 bp protected fragment is expected. The position of 
the primer extension probes (PE) are also shown. The 256 and 383 bp 
species represent the primer extension controls from primer A and B 
respectively. The lower coordinates represent those in the original 
plasmid (pSVBS2tkSupF) shown in (A). This map is not to scale. 
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Figure 15. 
Electrophoretic analysis of the products of Si nuclease 
protection. 
Lanes A, C, G, T are a sequence ladder of M13tg131 used to provide 
molecular weight markers. 
Lane 1: Si protection of yeast RNA (Si protection control). 
Lane 2: Si probe alone. Hpal-Ec0RV 1015 bp. 
Lanes 3 & 4: Si protection of the RNA from the 434 bp EcoRl- 
Acci fragment of pTK1. 
Lane 5: Si protection of poly A+ RNA from clone ES2. 
Lane 6: Si protection of poly A+ RNA from clone ES3. 
Lane 7: Si protection of poly A+ RNA from clone ES6. 
Lane 8: Si protection of poly A+ RNA from clone ES9. 
Table 4A. 
Si protection of the RNA from the 434 bp EcoRI-HpaI fragment 
from pTKi results in a protected band of 290 bp (see Figure 14). 
Protection of the poly A+ RA from clones stably transfected 
with the plasmid pSVBS2tkSupF yield the fragment sizes indicated. 









Electrophoretic analysis of the products of primer extension 
assay. 
Lanes A, C, G, T are a sequence ladder of M13tg131 used to provide 
molecular weight markers. 
Lane 1: Primer extension control. Extension product of the 434 bp 
EcoRI-AccI fragment of pTK1. 
Lane 2: Extension product of yeast RNA. 
Lane 3: Extension product of poly A+ RNA from clone ES3. 
Lane 4: Extension product of poly A+ RNA from clone ES6. 
Lane 5: Extension product of poly A+ RNA from clone ES9. 
Lane 6: Extension product from the 434 bp EcoRI-AccI fragment 
from pTK1 with the primer B (5151- 5169). 
Lane 7: Primer extension product of polyA+ RNA from clone ES6. 
Lane 8: Primer extension product of polyA+ RNA from clone ES2. 
Each RNA species was extended with the primer A (5020- 5042), in 
lanes 1-5 and primer B (5151-5169) in lanes 6-8. 
Table 4B. 
The table shows the expected sizes of extension products from primer 
A from extrapolation from the Si data. Also shown are the sizes of 
the observed extension products. 
Primer A 
A C G T 1 234 5 
- 	 462 
db _ 	 256 	Primer B 
I 220 ACGT 6 78 
-11111116- 200  
383 






LANE 	RNA SPECIES 	 SIZE OF PROTECTED 
FRAGMENT(s) (bp) 
3 & 4 SI CONTROL 290 
5 ES CLONE 2 124 
6 ES CLONE 3 280 + 276 
7 ES CLONE 6 318 + 	150 
8 ES CLONE 9 293 + 291 
SIZE OF EXTENSION PRODUCT(s) (bp) 
LANE 	RNA SPECIES 	EXPECTED 	 OBSERVED 	OBSERVED 
(from SI assay) 	PRIMER A PRIMER B 
(5020-5042) 	(5151-5169) 
1 & 6 	PRIMER EXTENSION 
CONTROL 256 + 383 256 383 
8 ES CLONE 2 * * 212 
3 ES CLONE 3 97 + 93 200 + 196 * 
4 & 7 ES CLONE 6 135 + * 220/214 + * * + 146 
5 ES CLONE 9 110 	+ 108 462 * 
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is 19 nucleotides long, is 50% GC rich and maps between coordinates 
5151 and 5169. The primers were end-labelled to high specific 
activity using T4 kinase. The annealing reaction was carried out at 
60°C (see Materials & Methods). As a control in these 
experiments the primers were hybridised to the RNA transcribed from 
a 434 bp EcoRI-AccI fragment of pTK1 inserted downstream of the 
T7 promoter. The extension of this RNA with Primer A yields a 
product which is 256 bp long. Primer B yields a 383 bp extension 
product (Figure 14b & c). These observed results are in agreement 
with the sizes expected (Table 4B). The products of the primer 
extension reaction are shown in Figure 16. 
The primer extension data does not agree with the Si data. 
Table 4B shows the expected lengths of the extension products 
obtained with RNA from each of the stably transfected clones. These 
values were extrapolated from the Si data. The observed results do 
not conform with the values predicted from the nuclease protection 
assays. Each primer extension product is longer than expected. 
The primer extension results map the start of transcription to sites 
upstream of those indicated in the Si assay. This was not an 
artefact of the reactions as the control RNA in both experiments 
yielded the expected products of 256 and 383 bp. An explanation is 
that rearrangement of the construct has taken place. The primer 
extension data indicates the position of the start of transcription. 
This data is consistent with the Northern blot data. The Si data 
shows the extent of hybridisation of the RNA to a Mup/tk DNA 
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specific sequence (Figure 17). The difference between the two 
termini represents sequences present in the transcript which are 
not a simple continuation of the foreign gene sequence, in the 5' 
direction, from the point at which homology with the Si probe ends. 
In principle this transition could be due to any discontinuity in 
the input sequence. There are several explanations for this. For 
example an insertion of DNA into, or deletion of DNA from, the 
transfected plasmid sequence. Alternatively the transition could 
represent the change from foreign DNA to chromosomal DNA as a result 
of the integration of a rearranged plasmid. 
In clones ES2 and ES6, interruption of the plasmid sequence has 
occurred 3' to the point at which Primer A hybridises. Thus the 
sequences complementary to the primer are not transcribed. This 
explains why Primer A was uninformative for analysing these clones 
(Table 4B). However, the break points do occur 5' to the site at 
which Primer B hybridises. This primer is informative for mapping 
the transcription start sites in these clones. The distances of the 
start sites map from 50 bp upstream (clone ES6) to 350 bp upstream 
(clone ES9) (Figure 18). 
None of the tk specific transcripts initiate from the probable 
BS2 CAP site. 
Only one of the tk-specific RNA's present in clone ES6 contains 
sequences which are complementary to Mup DNA. This is shown by the 




A figure to show the sequences at the site of rearrangement in 
clones ES2, ES3, ES6 and ES9 as mapped by Si nuclease assay. The 
arrows indicate the 5' boundary of the RNA/DNA hybrid. Also shown 
are the sequence and position of the two primers used in the primer 
extension assay, the thymidine kinase ATG, the Mup TATA box region 
and the proposed BS2 CAP site. The numbers represent the map 
coordinates in the original plasmid pSVEPBS2tkSupF. 
Ec0RV 	AAccI liSau96I 	A Sau3AI 
6CAB6AACAA ICCTTI3BCCT CTCATCP.TA AATAA TAT1CCACAA 
FCCT6ACAS ABSTAGASIC GACCCATCA 66A 
ACCCACT6AA CCCABABABIT_ ATAT643GcC AASCAAAGGA BCT6G66A6T 
4894 	 6 	 4925 	 4935 
CAP 
A6T6TRBB CAACATCACC f6AASAC6T G6ICCTABAI3 EATCGATCTT 
3 3 
-<j PolyFinTer t> 
6BT6t3CBTGA AACTCCCCA CCUTHESC AASCGCCTTSTABCt 
5020 	 5042 
71T(GCTTC6 TPCCCCTGCC ATCAACACCC GTCTBCGTIC 6ACC66C76 
Met 
 6 	Primer  
• 
C6C6TTCTCG cr6CCAT6C ACC6ACTA C1C'C&TT6C6 CCCTC6CC56 
2 
CASCAASAAS CCAC6AAGT CCECCTE6AB CASAAAAISC CCAC6CTICT 
5151 	 5169. 
6CTT1AT ATABC66TC CTCC66AT ESSSAAAACC ACCACCC6C 
Primer B 	5225 5230 
ACT6Cr66T B6CCCT6B&T 1C6C6CCA6 A 
I 	
I ' TATCGjc7A CTCCC6A6 
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Figure 18.. 
The composite DNA sequences that lead to active thymidine kinase 
ssion in clones of BHKtk cells stably transfected with the 
plasmid pSVBS2tkSupF. 
The boxed region represents the HSV thymidine kinase coding 
region separated from the Mup sequences (cross hatched box) by a 
Sau3AI site. The coordinates of the two primer extension primers A 
and B are shown. 
Components of the sequences which give rise to active thymidine 
kinase expression in the stably transfected clones ES2, 3, 6, 9. The 
boxed/hatched areas show the length of the protected fragment in 
base pairs as determined by Si nuclease mapping. This can 
incorporate thymidine kinase and Mup sequences. The Si probe is the 
1015 bpHpal-Ec0RV fragment (Figure 14A). The coordinates 
represent the points of rearrangements of the plasmid in each of the 
clones (see Figure 17). The true start of transcription is 
determined by primer extension assay. The amount of "adopted" 
DNA is given above each shaded box. The length of the extension 
product is shown underneath each map. 
4894 4935 
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CAP 	 5020 5042 	 5151 5169 
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which is transcribed constitutes 25 bp (Figures 17 & 18). This 
region does not include the Mup TATA box or the probable CAP site. 
RNA from clone ES9 hybridises to all of the tk DNA sequences. The 
break point in the plasmid DNA is mapped to the polylinker 
separating the tk and Mup sequences. Similarly RNA from clone 
ES3 is complementary to all but 13 bp of the tk sequence (Figure 
17). 
This data suggests that the integration of an intact copy of the 
plasmid pSVBS2tkSupF does not lead to correct thymidine kinase 
expression. 
The structure of integrated plasmid copies. 
The presence of plasmid rearrangements in each of the clones was 
analysed by enzymatic digestion of cellular genomic DNA. Southern 
blot analysis of these samples showed the presence of intact and 
rearranged copies in each cell line. The copy number of the plasmid 
was determined and this was compared to the level of HSVTK measured. 
Many rearrangements are observed in the stably transfected 
clones. 
The structures of the tk integrants in the genomes of stably 
transfected clones were investigated. The DNA was restricted with 
Hindlil + BamHI or with Mliii + BamHI. The plasmid has unique 
Hindili and Mliii sites and two BarnHI sites (Figure 19). 
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Hybridisation of a tic-specific probe to a Southern transfer of 
MluI and BamHI digested DNA revealed a prominent 1684 bp band in 
each of the clones (Figure 20). This fragment contains the tic 
coding regions which are necessary for survival under HAT selection. 
When the DNA was digested with Hindlil and BamHI, a band of 4071 
bp which is common to all of the clones was seen. This represents 
the intact Mup and tk coding sequences. The simplest pattern was 
observed in a Miul + BamHI digestion of DNA from clone ES9. Only 
two bands were observed. The predominant 1684 bp band could indicate 
tandemly arranged copies of the plasmid but the data is only 
informative for the regions between the two enzyme sites. In all of 
the remaining clones a large number of strongly hybridising bands 
are seen (Figure 20). All four clones contain some integral Mup 
and tic sequences but many rearrangements are observed. Primer 
extension and Si analysis have shown that those copies which harbour 
intact Mup coding sequences are inactive. Of the rearrangements 
probably only one needs to be actively expressed to ensure survival 
of the cell under selective pressure. I have probably therefore 
selected cells containing a productively rearranged plasmid which 
expresses thymidine kinase, amongst a host of silent intact and 
nonproductively rearranged copies. 
The number of integrated plasmid copies and HSVTK activity. 
The copy number of the integrated tic gene in the four stably 
transfected clones was determined by densitometric scanning of the 
autoradiogram (Figure 20). Each clone contained on average 6 copies 
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of the plasmid pSVBS2tkSupF. The highest number (10) was found in 
clone ES6 and the lowest (4) in clones ES2 and ES9. Clone ES3 
contains 8 copies. The copy number of the plasmid was compared 
directly to the level of HSV thymidine kinase present (Table 5). 
There is no correlation between copy number and HSVTK activity. Each 
clone has approximately the same amount of enzyme activity; 150 
units/mg protein. Survival of the cell in HAT medium necessitates 
the expression of only one of the plasmid copies. The constant level 
of TK activity in all of the clones could suggest that the relative 
strength of the promoter governing tk expression is about the same. 
However, the intensity of the bands which represent the products of 
the primer extension assay are different for each clone (Figure 16). 
The amount of polyA+ RNA used was the same in each case. The 
intensity of each band is in direct proportion to the amount of 
transcript which can be primed in the polyA+ RNA population. 
Clone ES3 has approximately twice the amount of primable message as 
ES6 and up to four times the amount of ES9 (Figure 16) yet all the 
clones have the same TK activity. This could suggest that the 





The figure shows restriction maps of the construct pSVBS2tkSupF 
showing the sites used to establish the copy number of the plasmid 
in stably transformed clones. The sizes of the expected fragments 
are shown. 
BarnHI + Miul digest. 
BamHI + Hindlil digest. 
BaxnHI 0 EcoRl 0 HindIll M Miul V PstI 
The underlined MluI-PstI region represents the extent of 
hybridisation of the 840 bp PstI-PstI fragment probe from PTKI. 
C). Schematic diagram of the pSVBS2tkSupF construct showing the 
delineation of the plasmid components by restriction sites. 
C 
1 k 
5117 	 1684 	345 A 
95 
B 	 2730 	 4071 
M 
pBR322 & 5V4O sequences 	BS2 	 1K 
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Figure 20. 
Southern blot of the genomic DNA from each of four clones and 
transfected with the plasmid pSVBS2tkSupF, restricted with the 
pairs of enzymes indicated and probed with the 840 bp PstI-PstI 
fragment from pTK1. 
Clone ES9 (9), ES6 (6), ES3 (3) and ES2 (2). 
Lane A: 10 copy number marker. The DNA is restricted with Hindill 
and BamHI. This gives a fragment of 4071 bp and a partial fragment 
of 4416 bp. 
Lane B: 5 copy number marker. The DNA is restricted with MluI and 
BamHI. This gives a 1684 bp fragment and a 2029 bp partial. 
Lane C: 1 copy number marker, as lane B. 
Hind 111+ BamHI 	 MIu I + BamH I 
A B 9 6 3 2 9 6 3 2 C 
4416  
4071 	- 	___ 
Sam 4am 




Clone 	Copy Number 	HSV Thymidine 	rnRNA levels 
Kinase activity (relative) 
C pmo 1/rn in/mg 
ES2 	 4 	 162 	 ? 
ES3 	 8 	 118 	 4 
ES6 	 10 	 193 	 2 
ES9 	 3 	 147 	 (1) 
Relationship between the copy number of thymidine kiriase sequences 
in cells stably transfected with the plasmid pSVBS2tkSupF and the 
resultant HSV thymidine kinase activity and relative rnRNA levels. 
75c 
CHAPTER 10. 
THE EFFECTIVENESS OF THE Mup BS2 PROMOTER IN THE INITIATION OF 
TRANSCRIPTION: 
DISCUSSION OF TISSUE CULTURE EXPERIMENTS. 
The fidelity of expression of transfected genes. 
The intrinsic ability of promoter sequences to initiate 
transcription can be assessed by their fusion to a selectable gene 
marker and transfection into a recipient cell line. One such 
selectable gene is the Herpes simplex virus type I gene coding for 
thymidine kinase. This enzyme is involved in the pyrimidine salvage 
pathway (Figure 5). Transfection and expression of this gene results 
in the stable conversion of BHKtJZ cells to a TK+ 
phenotype. Transfected cells grow in selective HAT medium because of 
the stable integration of one or more copies of the foreign DNA into 
the recipient genome. In assessing the function of a promoter by 
analysing the selectable gene product, the assumption is made that 
the expression of the gene is usually controlled by its own 
promoter. However, the effect of the chromosomal environment at the 
site of integration cannot be discounted. Studies on a number of 
selectable and non-selectable genes show that the fidelity of gene 
expression is sufficient to produce properly processed mRNAs of 
correct size which are polyadenylated and transported to the 
cytoplasm. However, the analysis of the 5' termini of certain 
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transfected genes has revealed some anomalies. Wold et al., (1979) 
studied rabbit -globin transcripts in transfected L cells. SI 
mapping revealed a 5' terminus about 45 nucleotides downstream from 
the natural 5' end. Dierks et al., (1981) also observed these 
aberrant transcripts but found that the great majority of PNAS were 
correctly initiated. There is still some question as to whether the 
truncated transcripts are a consequence of aberrant initiation or of 
post-transcriptional cleavage of correctly initiated messages. A low 
level of aberrant 5' termini have also been seen for HSVt]c mRNA 
(McKnight et al., 1981). In this case incorrect initiation was 
indicated by transcripts which were longer than normal. 
Aberrant transcripts following transfection of promoterless tk 
genes. 
Transfection of promoterless tic genes can give rise to HAT 
resistant colonies (Roberts & Axel, 1982; Puim & Knippers, 1985). 
When promoterless tic genes are used in transfection experiments 
the number of HAT resistant clones is 0.1-1% of the number obtained 
with an intact HSVt]c gene (McKnight & Gavis, 1980; Pulm & 
Knippers, 1985). Roberts & Axel, (1982) transformed aprt 
tic L-cells with a plasmid containing a wild type aprt gene 
and a truncated, promoterless tic gene. Transformants which 
integrated a single copy of the plasmid exhibited the aprt+ 
phenotype but remained tic in selective medium (Wigler et 
al., 1979). An RNA transcript of 0.9 kb was expressed. This is 400 
bp smaller than the normal tk message which is 1.3 kb long. Some 
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transformants containing a single copy of the wild type tk gene 
also expressed this 0.9 kb message. A third less abundant 1.1 kb 
message is also expressed by the promoterless plasmid. TK+ 
variants which contained a high copy number of the promoterless tk 
gene were also isolated. These copies have been shown to be 
organised in tandem arrays. Roberts & Axel, (1982) hypothesise that 
the truncated 0.9 kb mRNA message is initiated from an internal 
transcription start site within the tic coding region. Translation 
of this transcript produces a protein with reduced catalytic 
activity. Only when it is abundant is sufficient enzyme activity 
+ 
accumulated to permit phenotypic conversion from TK to TK 
Hiscott et al., (1980) demonstrated that amplification was 
responsible for selection at restrictive temperatures in a cell line 
containing an SV40 temperature sensitive A gene. Puim & Knippers 
(1985) also observed high copy number arrays, 10-25 per genome, of 
promoterless tic genes. Analysis of the polyA+ RNA from these 
clones revealed that the major RNA message was of the same size as 
that from a clone containing the intact tk gene. A smaller 
aberrant RNA was also detectable but this was not in excess of the 
longer mRNA species. In addition the thymidine kinase activities in 
these cell lines were the same as in lines transfected with normal 
genes. A cell line containing only 2-3 copies of the promoterless 
tic plasmid gave an RNA message of 1.3 kb. It was concluded that 
survival of truncated tic genes under selective conditions does 
not depend on the overproduction of aberrant tic transcripts. 
Instead at least one of the truncated genes is in optimal 
association with an active cellular promoter. This provides an 
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alternative way in which a promoterless tic gene is able to 
transform a TK cell population to TK+ phenotype. A 
consequence of this will be that the length of the tk message will 
depend upon the distance of the promoter from the tk coding 
sequences. 
Hiller et al., (1988) proved that the hypothesis of Pulm & 
Knippers (1985) was correct. From the low copy number cell line 
isolated by Puim & Knippers, they determined the structure of a 
surrogate promoter by isolating the integrant gene from a genomic 
library. Nucleotide sequencing data suggested that the transfected 
circularly closed plasmid DNA was apparently cut at a site 
immediately upstream of the tic sequence and joined via blunt end 
ligation to a cellular DNA segment in a reaction involving little if 
any sequence homology. The cellular DNA flanking the integrated tk 
sequence functioned as a surrogate promoter, since the 
transformation efficiency of a plasmid containing the tic sequence 
with associated mouse DNA was at least as high as the transformation 
efficiency of a plasmid carrying the intact tic gene with the 
authentic HSV promoter. Sequencing of the 5' promoter region 
revealed a TATA box element, two CCAAT boxes and a GC element with 
no similarity to any of the known thymidine kinase promoters. The 
CAP site of the cellular promoter has the same spatial arrangement 
to the coding sequences as the CAP site of the normal intact tk 
gene. This results in the observed 1.3 kb transcript. 
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In conclusion, the appearance of HAT resistant colonies in cells 
transfected with truncated promoterless genes should indicate the 
frequency with which active transcriptional promoters have been 
moved 5' to the integrated gene. In view of the low transformation 
efficiency of truncated tk genes this type of activation must be a 
rare event. 
Non horloQous recombination in mammalian cells: 
The site of integration of transfected DNA. 
Direct evidence for the integration of the DNA complex into 
mammalian cell DNA was obtained by Robins et al., (1981). They 
introduced the human growth hormone gene into rodent cells and 
showed by in-situ hybridisation methods that the complex is 
integrated at a specific site on one of the cell chromosomes. In 
each line the hybridisation was restricted to a single random 
chromosomal site which was different in different lines. The 
distribution of integration sites is unlikely to be tru ly random 
because the input DNA probably does not have equal access to all 
parts of the genome. The overrepresentation of repetitive sequences 
at integration sites argues for some unevenness in random 
integration (Wallenberg et al., 1984 & 1987; Kato et al., 1986). 
Kinnaird & Bishop (unpublished results) analysed several cell lines 
stably transformed to a TK phenotype with a BS6/HSV thymidine 
kinase gene. One of these lines on further examination was found to 
have integrated the transfected DNA into a middle repetitive 
sequence of the hamster genome. 
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Folger et al., (1982) and Brinster et al., (1985) suggest that 
exogenous DNA may integrate at pre-existing chromosomal breaks which 
determine and limit the number of integration sites. It may be a 
feature of repetitive DNA that it is inherently less stable than 
active gene sequences. This would account for the observation above. 
Random integration requires little or no sequence homology at 
junctions between foreign DNA and chromosomes. 
When foreign DNA integrates into a chromosome, it generates a rather 
distinct junction, usually with an abrupt boundary between foreign 
and chromosomal DNA. Recently information has become available on 
the nature of the DNA sequences at the site of integration (Kato et 
al., 1986). Transformants were obtained by the transfection of 
mouse tkL cells with a plasmid containing the entire 
thymidine kinase gene together with pBR322 sequences. DNA sequences 
containing cellular and exogenous DNA junctions in different rescued 
plasmids were recovered from several of the resultant tk+ cell 
lines by molecular cloning. The plasmids were analysed in detail by 
nucleotide sequencing and hybridisation techniques. No direct or 
indirect repeats, or any detectable sequence homologies between the 
exogenous and cellular DNAs near the junctions, were found at the 
site of integration. The absence of significant homology indicates 
that random integration probably arises from non-homologous 
recombination. 
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The structure of integrated DNA. 
The commonest outcome of DNA that is microinjected into mouse eggs 
is the insertion into one of the chromosomes of a single array of 
direct tandem repeats (head to tail configuration; see Palmiter & 
Brinster, 1986). Head to head and tail to tail arrangements, and 
also rearrangements of the foreign DNA, are rarely observed. 
Fragments of chromosomal DNA have been found embedded in arrays 
(Covarrubias et al., 1986; 1987) and insertion is sometimes 
accompanied by rearrangement in the flanking DNA sequences (Robins 
et al., 1981; Stringer, 1982; Wilkie & Palmiter, 1987; Mahon et 
al., 1988). Low concentrations of DNA tend to give transformants 
carrying fewer copies of the foreign DNA, which are often integrated 
as single copies at independent sites (Perucho et al.., 1980; 
Robins et al., 1981). 
The mechanisms involved in random integration. 
The events that accompany DNA integration are not fully understood. 
However, the observed structures of arrays are consistent with 
models based on the fate of DNA microinjected of transfected in cell 
culture. Molecules can become joined in two ways. The ends of linear 
molecules are joined randomly, by a DNA ligation mechanism, and it 
is probably in this way that foreign DNA fragments are incorporated 
into the chromosomal DNA. The structures of integration sites at 
which linear molecules have joined to chromosomes suggest that DNA 
free ends stimulate random integration directly. Most commonly, 
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linear molecules are joined to chromosomal sequences at or near the 
original ends of the input DNA (Folger et al., 1982; Thomas et 
al., 1986). 
The infrequent isolation of head to head and tail to tail 
arrangements suggests that the predominant head to tail arrays are 
not built up by the random joining of DNA ends (Palmiter & Brinster, 
1986). They seem to develop by some mechanism other than DNA 
ligation such as repeated cycles of reciprocal exchange. 
Microinjected or transfected linear DNA cannot form these 
concatemers by reciprocal exchange while it retains its original 
form. Presumably some of it becomes circularised by the joining 
together of the ends of the same molecule. Head to tail arrays could 
then be formed by reciprocal exchange between two circular molecules 
or between one circular and one linear molecule. The linearisation 
of supercoiled molecules in the cell has been proposed as an 
essential step in the process leading to the integration of 
transfected DNA copies. Indeed supercoiled DNA has been shown to be 
converted to linear and open circle forms (Weintraub et al., 
1986), and Folger et al., (1982) show that linear molecules yield 
a higher transformation efficiency (transformants per ug) than 
supercoiled molecules. 
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The productive reaarangement of transfected DNA can lead to the 
activation of gene sequences from a cellular promoter on 
integration. 
If circularized DNA molecules are broken randomly, they will form a 
population of circularly permuted linear molecules. Reciprocal 
exchange between such circularly permuted molecules can also 
generate tandem arrays. The combination of end to end ligation of 
fragments of linearised plasmids and the formation of arrays by 
reciprocal exchange allows for rearrangement of the foreign DNA 
sequences. The potential for expression of the foreign gene sequence 
on integration is dependent on the point at which the DNA is 
linearised. A rearrangement which retains the coding region of the 
transfected gene can be expressed if it integrates next to a 
cellular promoter in an active chromosomal environment. These are 
the requisites for a so called "promoter trap". Most plasmids will 
integrate as tandem arrays with the coding sequences in the correct 
spatial organisation. In this case expression of the transfected 
gene will be initiated from the intrinsic promoter. Other 
rearrangements will be non-productive and will be silent. Hiller et 
al., (1988) have proved that the activation at low frequency of a 
promoterless tk gene occurs by this mechanism of productive 
rearrangement followed by integration adjacent to an active cellular 
promoter. 
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The BS2 promoter is inactive in BHK fibroblast cells. 
BHKtk fibroblast cells were transfected with plasmids 
containing identical Sv40 and tk sequences and 2.2 kb of the 5' 
region of either Mup gene BS6 or BS2. The transformation 
efficiency of a plasmid containing the Mup BS2 promoter sequence 
was half that of an identical plasmid containing the Mup BS6 
promoter (Table 2). At first inspection this relationship could be 
indicative of the relative strength of each promoter (Gorman et 
al., 1983; Spandidos & Wilkie, 1983; Rutherford & Nienhaus, 1987). 
However, when RNA from several clones stably transformed with the 
plasmid pSVBS2tkSupF was analysed by Northern blotting, the tk 
specific transcripts were found to be very heterogeneous in size. 
None of the transcripts are of a size consistent with accurate 
initiation from the Mup BS2 CAP site and termination at the tk 
polyadenylation signal (Figure 12). 
Si nuclease and primer extension analysis was performed on 
polyA+ RNA from each of these clones. The results from the Si 
nuclease protection assay are shorter than expected. The Si nuclease 
data is effective in mapping a discontinuity in the foreign DNA 
sequence. This could be due to a rearrangement for example insertion 
or deletion of the transfected DNA or alternatively a transition to 
BHK chromosomal DNA. The primer extension assay establishes the true 
start of transcription and is consistent with the Northern blot 
data. None of the selected clones contains the BS2 CAP site and only 
one (clone ES9) produced any RNA transcribed from Mup sequences, 
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and this amounted to only 25 bp (Figure 18). It is concluded that 
the Mup BS2 promoter is not active in BHKtk fibroblast 
cells. This is supported by a lack of transient expression of the 
plasmid pSVBS2tkSupF (Table 1A). 
Tk sequences linked to an inactive BS2 promoter can be activated 
in the same way as promoterless tk genes. 
On the basis of the work described by Hiller et al., (1988) it is 
most likely that the tk sequences in the selected clones are 
activated by cellular promoter elements following the integration of 
a productively rearranged copy of pSVBS2tkSupF rather than the 
insertion or deletion of DNA into the plasmid sequence. The Si, 
primer extension and Northern blot data all agree with this 
hypothesis and the presence of rearranged copies of the plasmid are 
shown by Southern blotting (Figure 20). RNA sequencing was employed 
to show that BHK chromosomal DNA was responsible for the transition 
observed by the Si experiments. This did not yield a result. 
In cells transfected with the plasmid pSVBS6tkSupF, the fidelity 
of tk expression from the Mup BS6 CAP site is maintained giving 
a 1.47 kb transcript (Ghazal, 1986; Figure 12). On transfection, 
supercoiled plasmids are linearised prior to integration to generate 
a series of circularly permuted linear molecules which form a 
concatemer of tandem arrays by reciprocal recombination. The 
integration of arrays of plasmid pSSTBS6tkSupF will lead to active 
expression of tk from the BS6 CAP site. The Mup 3S2 promoter is 
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inactive in BHKtk cells even in combination with the SV40 
enhancer. The integration of tandem arrays of plasmid pSVBS2tkSupF 
will not result in the expression of tic from the Mup BS2 CAP 
site. Cells transfected with pSVBS2tkSupF can only actively 
express tk when a productively rearranged tic gene is integrated 
adjacent to an active cellular promoter. The distance of the CAP 
site of the cellular promoter from the tk coding region is 
reflected in the length of the tk specific transcripts. This is 
shown by the Northern blot and primer extension analysis (Figures 
12, 16 & 18). 
The transformation efficiency of pSVBS6tkSupF is higher than 
that of pSVBS2tkSupF. 
As a result of the Mup BS6 promoter being active and the BS2 
promoter being inactive, identical linearisation events will result 
in a greater proportion of pSVBS6tkSupF integrants being able to 
express HSV thymidine kinase. This accounts for the greater 
transformation efficiency of pSVBS6tkSupF compared to 
pSVBS2tkSupF. These events are summarised below 
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Structure of 	Integration at 	Expression of tk 
plasmid integrant 	active promoter 	BS6 	BS2 
Integral 	 NO 	 YES 	* 
YES 	 YES 	* 
Non productive 	 NO 	 * 	* 
rearrangement 	 YES 	 * 	* 
Productive 	 NO 	 * 	* 
rearrangement 	 YES 	 YES 	YES 
This visualisation of events allows the expression of tk from a 
cellular promoter in cells transfected with pSVBS6tkSupF. None of 
the selected clones show a major aberrant size message which is 
indicative of this event (Figure 12 & Table 3). It is likely that 
this is a bias in sampling a small number of clones. Northern blot 
analyses of clones HS2 and HS6 do show some very faint transcripts 
of aberrant size (Figure 12). In Northern blots a 340 bpPvull-
Hindlil fragment of pSVBS2tkSupF which contains the SV40 
promoter (Figure 9) and the plasmid minus the tk sequences does 
not cross-hybridise with any of these larger transcripts. This 
suggests that the extra long transcripts may be transcribed from the 
chromosome as a result of rearrangements although there is no 
evidence that they express an active tk gene. If the clones 
contain more than one copy of transfected plasmid it is likely that 
at least one of these will be intact and express the tk gene from 
the BS6 CAP site to give the major 1.47 kb transcript seen. 
Several reasons could account for the inactivity of the BS2 
promoter. 
The observed lack of expression of tk from the BS2 CAP site in BHK 
fibroblasts could suggest that an enhancer in the BS2 sequence is 
defective or that the promotional strength of the BS2 promoter is 
insufficient to produce enough TK to broach the threshold level for 
survival under HAT selection. Alternatively, a mutation may have 
disrupted a transcriptional activator protein binding site which 
results in a consequent lack of transcription. Several sequence 
anomalies of the BS2 sequence (compared to BS6) are observed which 
could support either of these hypotheses (Chapter 5). A further 
possibility is that BHK fibroblasts lack a trans-acting factor 
which is absolutely required for the initiation of transcription at 
the BS2 CAP site. 
SV40 enhancer sequences may increase the transformation 
efficiency of plasmid pSVBS2tkSupF relative to pOtk. 
The mechanism of activation of tk in cells transfected with the 
plasmids pOtk and pSVBS2tkSupF are concluded to be the same. 
Clones which have been transformed with pOtk show heterogeneity in 
the sizes of tk specific RNA transcripts, consistent with the 
activation of tk by a cellular promoter (Hiller et al., 1988; 
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Figure 13). No transient expression of the plasmid is observed. This 
is consistent with the absence of a promoter in the construct 
(Tables 1A & B). However, the transformation efficiency of 
pSVBS2tkSupF is approximately 12 times that of pOtk (Table 2). 
This apparent discrepancy could be due to the influence of the SV40 
enhancer and early promoter sequences present in pSVBS2tkSupF. 
Enhancer sequences may directly or indirectly stimulate 
recombination perhaps by making the recombinant plasmid a better 
substrate for recombination or by bringing the recombinant plasmid 
into a region of high recombinational activity. Alternatively, 
enhancer sequences may stimulate DNA-mediated transformation by 
increasing the probability that a gene is active after its 
integration into the host chromosome. A gene with an associated 
enhancer may be active in a usually silent chromosomal environment. 
In the latter model enhancer sequences may function by altering 
local chromatin structure so as to facilitate transcription of an 
associated gene. 
There is evidence to show that when SV40 sequences are present in a 
transfected plasmid they remain close to the tk sequences when 
expression is directed from a cellular promoter. Puim & Knippers, 
(1985) transfected mouse fibroblast tk cells with a plasmid 
containing the SV40 enhancer linked to a promoterless tk gene and 
isolated 3 low copy number integrants. Maps of the integrants were 
constructed by blot hybridisation. Two of the integrants had a 
mosaic structure. This consisted of an intervening piece of cellular 
DNA separating the tk gene SV40 element from other sections of the 
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plasmid which also includes small parts of the SV40 enhancer. The 
integration of the SV40 sequences close to a cellular promoter may 
enhance transcription from the promoter so that enough gene product 
is produced to ensure survival in HAT medium. Murnane (1986) 
transfected a permanent human cell line with a plasmid containing 
the Sv40 early promoter and a promoterless neo gene. Southern blot 
analysis of five G418 resistant subclones indicated that there were 
heterogeneous rearrangements in the region of the neo gene which 
were unique to each subclone. In one subclone the rearrangement was 
a tandem duplication that resulted in the relocation of the SV40 
promoter 5' to the neo gene. There is no evidence that the SV40 
enhancer does remain in the vicinity of the tic gene in clones 
stably transfected with pSVBS2tkSupF. Another hypothesis is that 
the mouse Mup sequences could promote integration. 
The effect of the SV40 enhancer sequence on the expression of 
the transfected DNA. 
The HSVtk gene can be accurately expressed from a BS6 Mup 
promoter in BHKtk cells only when it is linked to an 
enhancer. In clones isolated after transfection with pSVBS6tkSupF 
it is not known whether all of the copies of the foreign gene retain 
the Sv40 sequences. A proportion of active integrants may have lost 
the SV40 enhancer but may be activated by cellular enhancer 
sequences. Work carried out by Hamada (1986a; 1986b) is pertinent in 
this case. They describe an "enhancer trap" which hinges on the 
observation that the SV40 promoter is enhancer dependent. The 
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expression of chromosomally integrated enhancerless and enhancer-
containing genes were analysed. An enhancerless plasmid containing 
the SV40 early promoter linked to a chioramphenicol 
acetyltransferase (CAT) gene was co- transfected with a cloned tk 
gene into murine tk L cells. TK+  colonies appeared at a 
frequency of 5x10 6. The CAT activity in TK+  transforruants 
showed that the enhancerless CAT gene was as actively expressed as 
an SV40 enhancer containing transformant. Furthermore polyA+  CAT 
specific RNA transcripts were of a size consistent with initiation 
from the SV40 promoter. These results were consistent with the 
activation of transcription of the CAT gene from the SV40 promoter 
by an endogenous cellular enhancer. Using this selection system two 
gene activator elements were isolated from cloned human DNAs 
(Hamada, 1986b). They show functional and structural properties 
characteristic of other enhancers (Chapter 5). 
Ghazal (1986) found that in cells transfected with pSVBS6tkSupF 
the Mup BS6 promoter was used in preference to the SV40 promoter. 
From the work described above it could be concluded that the SV40 
sequences were absent and the Mup promoter was activated by 
endogenous enhancers. This does not seem to be the case as TK+ 
colonies were isolated at a high frequency of 3x10 4  
transformants/cell (Table 3). 
NB [Frequency calculated at 182 colonies per 3x(2x105) cells.] 
The level of HSVTK activity in each of the transfected clones is 
constant. 
I-ISV thymidine kinase activity was measured in a number of clones 
stably transformed with a variety of plasmids (Table 3). 
Surprisingly, the level of activity was approximately the same in 
each transformant. 
Pulm & Knippers (1985) found that a promoterless tic gene was as 
actively expressed as an intact tic gene when transfected into 
mouse Ltk cells. Hamada (1986a) showed that in the random 
isolation of enhancers from the human genome using an enhancer trap, 
surrogate enhancers were adopted resulting in a level of activity 
which was the same as that measured in cells containing the SV40 
enhancer. Lang et al., (1983) replaced the endogenous tic 
promoter with exogenous transcription control sequences from the 
human c-globin and mouse 	major globiri genes and the SV40 and 
Moloney murine sarcoma viruses. Transfection of these constructs led 
to stable transformants with similar levels of tic activity. It is 
possible that only strong promoters, sufficient to raise tk 
expression above the required survival level, were selected in these 
experiments. 
The 5' termini of tk specific RNAS could affect their 
translational efficiency. 
The primer extension results show that clone ES6 has approximately 
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four times the amount of tk specific polyA+ RNA as the other 
clones (Figure 16) although it does not have elevated TK activity 
relative to the other clones (Table 3). This suggests that TK 
activity is regulated by some post-transcriptional mechanism. Primer 
extension analysis has shown that the RNAs from each of the clones 
have different 5' termini. Differences in the translational 
initiation signals of the adopted promoters may result in RNA 
transcripts with different translational efficiencies. The 
efficiency of translation is also affected by the primary and 
secondary structures of the rnRNAs in the region of the ribosome 
binding site. These are likely to be different for each of the RNA 
transcripts. Al Shawi et al., (1988) analysed the expression of a 
Mup-BS6/tk hybrid gene in transgenic mice in which tk 
expression is initiated from the Mup CAP site and consequently all 
tk specific transcripts have the same 5' terminus. The levels of 
tk mRNA and enzyme activity were found to be in broad agreement in 
different tissues and different lines. 
The extent of HSVtk coding sequences within clones stably 
transfected with pSVBS2tkSupF. 
Southern blot analysis of genomic DNA from individual cell clones 
cut with pairs of enzymes shows (by the criterion of fragment 
length) that some integrants have spatially intact Mup and tk 
sequences but that many rearrangements are also observed (Figure 
20). Integrants containing intact Mup BS2 sequences are inactive. 
Of the remaining copies present in the clone probably only one needs 
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to be actively expressed from a cellular promoter to ensure survival 
of the cell under selective pressure. The analysis shows that there 
is no relationship between plasmid copy number and HSVtk activity 
(Figure 20 & Table 5). It is concluded that the selected clones 
contain a productively rearranged plasmid which expresses tk 
amongst a host of silent intact and nonproductive copies. Additional 
rearranged copies integrating next to weak promoters may result in 
the large faint tk specific transcripts present in the clones 
(Figure 12). 
The first 100 base pairs of the tk coding region are NOT 
essential for survival in HAT. 
Clone ES6 has two major tk specific transcripts (Figure 15 & 18). 
These are presumed to be messages from two fortuitous integrations 
following productive rearrangement of the transfected plasmid. The 
productively rearranged sequences which give rise to tk expression 
in clones ES3 and ES9 contain most of the tk coding region 
(Figures 17 & 18). Exceptions are clones ES2 and ES6 which lack 
approximately 100 and 80 bp of 5' tk coding region downstream of 
the translation initiation codon (Figure 17). This result shows that 
the first 100 bp of the tk coding region are not essential for 
survival in HAT medium. The tic protein translated from the short 
RNA in clone ES2 may have reduced activity. However its expression 
in sufficient quantities from an endogenous promoter could ensure 
survival and selection. Sequence analysis reveals the presence of 9 
potential translation initiation codons in the first 400 bp of the 
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tk coding region (data not shown). Any of these could be used in 
the absence of the natural fMET codon. These results delineate an 
essential length of tk sequences which when translated allow the 
conversion of a cell from the TK to TK+  phenotype. Analysis 
of the size of the protein would have to be undertaken to see which 
initiation site was actually being used. In the case of the clone 
ES6, which produces two tk specific transcripts, both messages 
could code for a functional thymidine kinase. 
go 
CHAPTER 11: ANALYSIS OF THE EXPRESSION OF THE Mup BS2 PROMOTER 
USING TRANSGENIC MICE. 
Introduction. 
Group 1 and group 2 Mup genes have evolved together in a 45 kb 
unit (Clark et al., 1984b; Bishop, 1985) and can be distinguished 
on the basis of nucleic hybridisation results. Group 1 genes are 
classified as hepatic type genes (see Chapter 1) and although group 
2 genes are linked to them in a 45 kb palindrome, there is no 
evidence to suggest that they are endogenously expressed in the 
liver. Indeed the Mup gene BS2 is presumed to be a pseudogene in 
the context of BS6 by virtue of lesions it contains in its protein 
coding sequence. Consistent with this observation, no BS2 specific 
transcripts are found on hybridisation of RNA from several Mup 
expressing tissues with a BS2 specific oligonucleotide probe (Shahan 
et al., 1987b; McIntosh & Bishop, 1989). It is illogical to assume 
that the BS2 promoter sequence is unable to initiate transcription 
of heterologous coding sequences from the putative CAP site. 
Sequence analysis reveals that the BS2 promoter has all the 
essential cis components that define a eukaryotic promoter, 
including recognition sites for various nuclear binding factors. In 
addition, several features which may alter promoter strength and/or 
tissue specific expression relative to BS6 have been observed (Clark 
et al., 1985; Chapter 5). The results (presented in this thesis) 
of transient and stable transfectiori assays with SV40 or Mup/tk 
hybrid genes, show that the BS2 promoter is not activated in 
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BHKtk cells. As BHK fibroblasts do not endogenously express 
high level expression of BS2 may well require multiple tissue 
and hormone specific factors which are absent in fibroblasts. 
The use of transgenic mice in gene expression studies. 
In order to study regulated gene expression in an environment which 
is more compatible to that in which the endogenous gene is normally 
expressed transgenic animals are used. Gene expression in 
transgenic mice resembles the endogenous counterpart much more 
closely than that observed after gene transfer into tissue culture 
cells. Transgenic animals are a powerful experimental system in 
which to define the regulatory sequences involved in the 
differential expression of genes. The regulation of gene expression 
is investigated in transgenic mice by the gene transfer of specific 
DNA sequences which are carried in the mouse germ line. Transgenic 
mice have been useful for defining the cis- acting regulatory 
elements of a number of tissue specific and developmentally 
regulated genes including s-globulin, elastase, insulin anda-
fetoprotein (Palmiter & Brinster, 1986; Cuthbertson & Klintworth, 
1988; Gordon, 1989; Westphal, 1989). 
Tissue specific expression of Mup genes and sexual dimorphism. 
Pertinent to the work carried out in this thesis are two papers 
which deal specifically with the regulation of Mup gene expression 
in transgenic mice (Al Shawi et al., 1988; Held et al., 1989). 
Al Shawl et al., (1988) introduced a MUp/HSV thymidine kinase 
transgene containing 2.2 kb of group 1 gene BS6 5' promoter region 
into mice. Held et al., (1989) used a Mup (BL6)/SV40 T-antigen 
hybrid containing 2.5 kb of 5' flanking region. Consistent with the 
classification of group 1 genes as hepatic type genes, expression of 
the reporter function was observed in the liver of transgenic 
offspring in both cases. This pattern of expression of the transgene 
shows that the sequences necessary for liver specific expression of 
BS6 and BL6 are located within the first 2.5 kb of DNA upstream of 
the CAP site. That the liver specific cis-acting sequences are 
located more than 350 bp away from the BS6 CAP site has been shown 
in transgenic mice harbouring a transgene containing only 350 bp of 
BS6 5' flanking sequence. Analysis of mPNA from various tissues and 
assays for thymidine kinase activity showed that liver expression 
had been abolished (Al Shawi & Bishop, personal communication). 
Expression of the 2.2 kb Mup/HSVtk transgene (Al Shawl et al., 
1988) was lower in female than male liver in several lines and the 
same sex difference was observed in the rate of run-on transcription 
of the foreign gene in liver nuclei. When females of one of the 
sexually dimorphic lines were treated with testosterone, the levels 
of HSVtk RNA and TK activity were increased, although not to male 
levels. In these aspects of liver expression and lack of expression 
in 7 other tissues, this hybrid gene exhibits many of the 
characteristics of an endogenous group 1 gene. 
A BS6/tk hybrid gene is misexpressed in the preputial gland and 
testis of transgenic mice. 
Misexpression of the Mup/HSVtk transgenes containing either 2.2 
kb or 350 bp of 5 BS6 flanking region was observed in the testis 
and the preputial gland (Al Shawi et al., 1988 & personal 
communication). Held et al., (1989) also observed expression of 
the BL6/SV40-T transgene in the preputial gland. The rat homologues 
to Mup,c2u-globulins, show a similar pattern of gene 
expresssion to endogenous mouse Mup genes (Laperche et al., 
1983, Maclnnes et al., 1986). One difference is that q.2u-_ 
globulin is expressed at a high level in male and female preputial 
gland (Held & Gallagher, 1985). Evidence suggests that an 
evolutionary difference in cis-acting regulatory elements appears 
to be responsible for the synthesis of 2u-globulins in the rat 
preputial gland, in contrast to the lack of detectable Mup in the 
mouse preputial gland (Held & Gallagher, 1985). A rat c2u-
globulin transgene was consistently expressed at very high levels in 
mouse preputial glands (da Costa Soares et al., 1987). This shows 
that the lack of expression of endogenous mouse Mup genes in the 
preputial gland cannot be explained by the absence of trans-
activating factors. Misexpression could be attributed to silencer 
sequences which normally inhibit the expression of the endogenous 
Mup gene in the preputial gland and the testis, but which are 
located outside the promoter regions included in the hybrid 
constructs. Alternatively, a transgene might contain newly created 
sequences which activate expression in non-specific tissues. This 
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hypothesis is unlikely since the expression of both the BS6/tk and 
the BL6/Sv40-T transgenes are observed in the preputial gland of 
different transgenic mice (Al Shawi et al., 1988; Held et al., 
1989). 
Misexpression of the BS6/tk gene in the testis and preputial 
gland are probably due to different causes. 
Testicular misexpression could be due to the same cause as preputial 
misexpression. If this were the case, a2u-globulin expression in 
the rat testis might be expected. However, no x2u-globulin 
specific m1NA is detected in this tissue (Al Shawi et al., 
personal communication). This observation suggests either that 
misexpression of the hybrid Mup gene in the preputial gland and 
the testis has different causes, or that there is a common cause 
independent of the causes of a2u-globulin expression in the rat 
and mouse preputial glands. 
Two observations (Al Shawi et al., 1988) suggest that different 
causes do bring about the misexpression of the hybrid gene in the 
preputial gland and testis. First, expression in the testis occurs 
in a transgenic line with no preputial gland expression. Secondly, 
tissue specific mRNAs differ in size. The absence of preputial gland 
expression in one line, 64 (Al Shawi et al., 1988), seems to be 
due to a position effect such that the expression of the gene is 
under the influence of flanking DNA sequences at the site of 
integration. This has been shown directly by cloning out the 
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transgene (using SupF) in line 64 and reintroducing it into 
recipient mice. Thymidine kinase assay analyses of the tissues of 
the resulting transgenic offspring show expression of the transgene 
in the preputial gland (Al Shawi et al., 1989). This is direct 
evidence of the effect of chromosomal position on transgene 
expression. 
Testicular misexpression. 
The actual cause of testicular misexpression remains unclear. 
However, the evidence implicates both the Mup promoter and the 
tk coding region as being important in determining this expression 
pattern. When present together, as in the BS6/tk transgene (with 
or without SupF), the expression of tk in the testis is very 
high and these mice are sterile (Al Shawi et al., 1988). When each 
component is present individually in a transgene, testicular 
expression of the reporter gene is observed at low levels for 
example Mup BS6/neo transgene (Jones, 1989 personal 
communication); Mup BS6/_a2u-globulin (Al Shawi, 1989). These 
mice are characteristically fertile. Some lines of mice transgenic 
for HSVtk linked to the mouse mammary tumour virus long terminal 
repeat expresses HSVtk in the testis (Ross & Salter, 1985) and are 
also sterile. In addition a HSVtk gene under the control of its 
own promoter was expressed in the testis (Kiessling et al., 1986). 
One of these mouse lines was fertile showing that the expression of 
tk in the testis does not invariably lead to sterility. In 
contrast a Mup(BL6)/Sv40 T-antigen hybrid gene is not expressed in 
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the testis (Held et al., 1989). This could be because different 
Mup genes were used or that the SV40 T-antigen gene can not act in 
conjunction with the Mup promoter to initate transcription in the 
testis. There is evidence to show that the tk gene can influence 
the transcription of attached heterologous promoters. Koltunow et 
al., (1987) show that the efficiency of an avian keratin promoter 
could be increased about 20 fold in Xenopus oocytes when attached 
to the HSVtk gene. 
HSVTK activity and sterility. 
Available evidence suggests that a high level of HSV thymidine 
kinase activity in one or more testis cell type is the likely cause 
of male sterii'ty (Al Shawi et al., 1989) although one exception 
has been documented (Kiessling et al., 1986). The enzyme could 
exert an effect in a number of ways which disrupt the cellular 
metabolism of nucleic acid precursors. These effects could stem from 
the expression of viral thymidine kinase at times in the cell cycle 
when when the cellular enzyme is normally repressed (Hofbauer et 
al., 1987) or from the enzyme having a different substrate 
specificity to cellulartk (Jamieson et al., 1974). In this 
respect HSVTK can efficiently phosphorylate deoxycytidine which can 
inhibit the normal pathway of pyrimidine phosphate metabolism 
(Kelly, 1983). 
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Expression of a Mup-BS2/HSVtk hybrid gene in transgenic mice. 
RESULTS. 
A 4485 bp HindIII-KpnI fragment containing approximately 2.2 kb 
of BS2 5' flanking region and the HSV thymidine kinase coding region 
was purified from the plasmid pSVBS2tkSupF; coordinates 2635-7120 
(Figure 9). To facilitate the rescue of the hybrid gene from the 
genomic DNA of transgenic mice, the construct contains the bacterial 
amber suppressor tRNA gene SupF (Goldfarb et al., 1982). The DNA 
was microinjected into fertilised F2 eggs derived from F1 
females [C57BL/6 x CBA/Ca] crossed with [C57BL/6 x CBA/Ca] F1 
males and the eggs transfered to the oviducts of pseudopregnant 
foster mothers. of the pups born, 6 were identified as being 
transgenic: 5 males and 1 female. The males BST A and BST B were 
mosaics. They were fertile but did not transmit the transgene so no 
G1 offspring were produced or lines established. The G0  
female transmitted the transgene at a frequency of about 50% to 
establish a line BST C. The males BST D, BST E and BST F and 
males from line BST C were all sterile (Table 6). 
The copy number of the transgene in line BST C is 1-2 (data not 
shown). Keeping to the nomenclature in Al Shawl et al., (1988) a 
line is a group of male and female mice descended from the same 
G0 female and containing the same transgenic insertion of foreign 
DNA. 
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Expression of the hybrid gene was studied by probing Northern blots 
with probes specific for HSVtk and by assaying HSV thymidine 
kinase activity in tissue homogenate supernatants. The presence of 
0.4mM TTP in the assay has been shown to inhibit endogenous 
thymidine kinase activity by about 93-97%. The same amount of TTP 
inhibits HSV thymidine kinase by about 50% so that relatively low 
levels can be measured quite accurately (Jamieson & Subak-Sharpe, 
1974; Al Shawi et al., 1988). 
In the following analysis the HSVTK activity data for mice BST D, E 
and F was compiled by Lisa Smith (PhD student). 
HSVTK activity was detected consistently in the liver and 
testis of transgenic mice. 
Foreign HSVtk mPNA and thymidine kinase activity was found 
consistently in the testis of all male G0 mice and in male 
offspring of line BST C (Table 8). Expression consistently occurred 
in the livers of male and female mice from line BST C and the livers 
of BST D, BST E, BST F. In addition very low levels HSVTK were 
detected in the preputial glands of mice BST D and in the brain of 
mouse BST E (Table 7). No activity was observed in any of the mice 
in the kidney, salivary gland, lachrymal gland or muscle (Table 7). 
The amount of HSVTK expression in the liver is low for each 
integration, ranging from 0.24-0.6 U/mg protein. In comparison the 
associated testicular expression is very high, typically in a range 
of 37-83 U/mg protein (Table 8). In addition the enzyme activity in 
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Table 6. 
Transmission of foreign genes from Go to Gi transgenics. 
Go MICE 	 SEX 	 G1 OFFSPRING 
TOTAL 	TRANSGENIC 
BST M 38 	 0 
BST M 20 	 0 
BST C (+ line) F 17 	 8 
BST M 0 	 0 
BST M 0 	 0 
BST M 0 	 0 
Table 8. 
HSV thymidine kinase activities in male tissues of transgenic mouse 
lines. Units (formation of lpmol TMP/min) per milligram of protein; 
means and standard errors. Parentheses indicate number of mice used for 
analysis. All values are calculated over background (non transgenic 
litter mates) except for BST C. 




BST A 0.019 (1) 4.47 	(1) 
BST B 0.017 (1) 23.3 	(1) 
* BST C 0.6 ± 0.045 	(2) 83.0 + 23.2 	(2) 
BST D 0.55 (1) 37 	(1) 
BST E 0.24 (1) 86 	(1) 
BST F 0.3 (1) 67 	(1) 
* Gi mice. 
0.066 (1) 
0.025 (1) 






A table to show the HSV thymidine kinase activities in tissues of 
transgenic mice, from line BST C, and control mice (non-transgenic 
litter mates). 
Numbers are the mean HSvtk activity in the presence of 0.4mM TTP. 
Parentheses indicate number of mice used for analysis. 
TISSUE 	 TR1NSGENIC 	 NEGATIVE (controls) * 
MALE (2) 	FEMALE (2) 	MALE (2) 	FEMALE (2) 
LIVER 	0.60 + 0.045 	0.40 + 0.08 	0.04 + 0.04 	0.024 + 0.005 
TESTIS 	83.0 + 21.2 
	
0.95 ± 0.9 
PREPUTIAL 	0.14 + 0.06 
	




0.11 ± 0.014 	0.13 ± 0.03 	0.14 + 0.02 
SALIVARY 	0.04 + 0.024 	0.03 + 0.007 	0.05 + 0.04 	0.05 + 0.03 
GLAND 
LACHRYMAL 	0.19 ± 0.13 	0.04 ± 0.05 	0.02 ± 0.13 	0.05 ± 0.04 
GLAND 
MUSCLE 	0.07 ± 0.09 	0.03 + 0.03 	0.08 ± 0.06 	0.02 + 0.02 
BRAIN 	0.36 ± 0.25 	0.25 + 0.08 	0.40 ± 0.25 	0.27 + 0.05 
* pmol(TMP)/min/mg at 370C; means and standard errors. 
the livers of male and female mice from line BST C were 
approximately the same and do not appear to exhibit sexual 
dimorphism (Table 7). 
Line-specific differences. 
Two features of the expression of the foreign gene are line 
specific: 
the occasional expression of the HSVtk gene in the brain in 
mouse BST E and in the preputial gland of mouse BST D. 
The relative levels of expression of the transgene in different 
tissues (Table 8). 
Sterility of males that carry the transgene. 
The two fertile mice BST A & BST B were mosaic and did not transmit 
the transgene. The remaining G0 males and male offspring from 
line BST C were sterile. All these mice show a high level of HSVTK 
activity in the testis (Table 8). Al Shawi et al., (1988) show 
that the probable cause of sterilty in mice carrying a BS6/tk 
hybrid gene is a high level of thymidine kinase expression in the 
testis. These results are consistent with this theory. Female mice 
from line BST C were fertile. 
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Northern blot analysis of HSVtk specific transcripts in mice 
from line BST C. 
Expression of the hybrid gene in mice of both sexes in line BST C 
was studied by probing Northern blots of liver and testicular RNA 
with an 840 bp HSVtk specific DNA fragment from pTK1 (Figure 21: 
samples B & D). RNA from the preputial gland, lachrymal gland, 
salivary gland, heart, muscle and brain was not analysed on the 
basis of the HSVTK enzyme assays. Clark et al., (1985) define the 
group 1 BS6 CAP site by primer extension and SI mapping of Mup 
mRNA. Sequence alignment of the BS6 and BS2 genes positions the 
potential BS2 CAP site at 30±1 bp downstream of the TATA box 
(Figure 7). The expected size of a transcript running from the BS2 
CAP site to the tk polyadenylation site is approximately 1.3 kb 
(1.45 with polyA). An RNA of approximately this size (1.42 kb) was 
detected in male liver RNA and in the testis RNA (1.3 kb; Table 9). 
The amount of this RNA is lower in the liver than in the testis 
(Figure 21: samples B & D). This is in agreement with the HSVTK 
assay. Each tissue contains a second smaller RNA of 0.9 kb. This 
reacts with the tk probe to the same extent as the 1.4 kb band in 
the liver and to a lesser extent to the 1.3 kb band in the testis. 
In addition the liver shows an additional faint transcript of 1.23 
kb. 
The smaller 0.9 kb band was presumed to be consistent with 
transcription initiation from cryptic start sites within the tic 
coding region, a phenomenon previously observed in cell lines 
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carrying integrated HSV tk genes (Roberts & Axel, 1982). However, 
a single stranded riboprobe specific for the sense RNA from the 5' 
tk coding region (Figure 14B & C; EcoRI-Ec0RV) fails to 
hybridise to the 0.9 kb band in testicular RNA from a mouse line 
transgenic for a BS6/tk hybrid gene (C. Jones, personal 
communication). This supports the hypothesis that the 0.9 kb 
transcript is an antisense initiate. Probing of liver transcripts 
from this line, or testis and liver transcripts from line BST C have 
not yet been performed, but it is likely that the results would be 
consistent between different lines and tissues. 
Comparison of the BS6/tk and BS2/tk hybrid gene transcripts. 
Figure 21 shows an autoradiogram of a Northern blot of the tk 
specific transcripts from the testis and liver of a mouse from line 
58 containing a BS6/tk transgene (Al Shawi et al., 1988) 
compared with those from a BS2/tk transgene. Table 9 shows the 
sizes of these transcripts as measured from the autoradiogram and 
Table 10 shows the mean 1ISV thymidine kinase activity in these 
tissues from each line. 
Testicular transcripts. Tk specific transcripts in the testes of 
both BS6 and BS2 transgenic mice are identical in length running at 
1.3 and 0.9 kb (samples A & B). The 1.3 kb band is consistent with 
initiation at the Mup promoter and termination at the tk 
polyadenylation site in each case. Primer extension and Si analyses 
are currently being carried out to confirm this. The observed 0.9 kb 
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message is very likely to be an antisense transcript on the basis of 
recent work previously described (see above). 
The intensity of the hybridising bands are approximately the same 
for the two transgenes and this is consistent with the similarities 
in the levels of HSV thymidine kinase activity measured (Table 10). 
Liver transcripts. The expression of the two transgenes in the 
liver results in two identically sized transcripts of 1.42 and 0.9 
kb (samples C & D). The 1.42 kb transcript is consistent with 
initiation at the Mup promoter and termination at the tk 
polyadenylation site and is the same size as the transcript 
intiating from the Mup BS6 CAP site in BHK fibroblasts (Table 3). 
Primer extension and SI mapping would be needed to confirm this. The 
difference in size between the transcripts observed in the testis 
and the liver may well reflect heterogeneity in the length of the 
polyA tail. The expression of the two transgenes seem to differ in 
the presence of an additional 1.34 kb transcript observed with BS6-
tk (Sample C; Figure 21) and a 1.23 kb transcript with BS2-tk 
(Sample D). However, the small 1.23 kb transcript may also be 
presented in the BS6/tk sample but is obscured by the strong 1.42 
kb signal. These additional transcripts possibly emanate from the 
Mup CAP site in each case, but differences in the length of the 
poly A tail results in the observed sizes. Another possibility is 
that the extra bands are antisense transcripts. Probing of the RNA 
with a sense strand-specific HSVtk riboprobe will help to confirm 




An autoradiogram of a Northern blot to show the sizes of HSVtk 
RNA in tissues from mice containing different MUP/tk transgenes. 
Total cellular RNA from the testis and liver from an adult male 
mouse was applied to a 0.8% formamide gel and after blotting the 
filter was hybridised with a 840 bp PstI DNA fragment from pTKI. 
TESTICULAR RNA. 
Sample A: shows 1) 30ug and 2) 15 ug of testicular RNA from mouse 
line 58 containing a Mup BS6/tk transgene. 1 day exposure. 
Sample B: as A except the RNA is taken from mouse line BST C 
containing a Mup BS2/tk transgene. 
T T7t'D T31,77%  
Sample C: two exposure 1) 7 days 2)+3) 2 days of RNA from line 58 
(male). 
Sample D: two exposures 1) 7 days 2)+3) 4 days of RNA from line BST 
C (male). 25 ug of RNA was loaded in each case. 
M = HSVtk specific markers (Figure 14B). 
-ye = non transgenic testis RNA (line 58). -ye RNA samples from each 
tissue from each line were analysed. All were negative with respect 
to HSVtk specific RNAs. 
TESTIS 	 LIVER 
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Table 9. 
A table to show the sizes of HSVtk-specific transcripts in total 
cellular RNA extracted from tissues of transqenjc mice. 
TRANSGENE 	EXPECTED SIZE 	ACTUAL SIZE OF TRANSCRIPT 
(bp) to the tk poly- 	IN TRANSGENIC MICE (bp). 
adenylation site. TESTIS 	LIVER 









To show the average levels of HSV thymidine kinase activity 
(pmol(TMP)/min/mg) means and standard errors in tissue samples from 
a mouse line containing either a BS6/tk (line 58) or a BS2/tk 
(line BST C) hybrid gene. 
* Data taken from Al Shawi et al., (1988). 
TRANSGENE 
* MUP BS6-tkSupF 	MtJP BS2-tkSupF 
TISSUE 	 LINE 58 (3) 	 LINE BST C (2) 
TESTIS 	 31.0 + 10 	 83.0 ± 21 
LIVER 	 5.8 + 1.15 	 0.6 ± 0.04 
PREPUTIAL 	 9.9 + 2.6 	 0 
GLAND 
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line specific position effects. Extra lines of transgenic mice will 
be required to resolve problem this by comparison. 
The amount of tk-specific RNA in the liver of a mouse from line 58 
is greater than that observed for line BST C (Figure 21). This is 
consistent with the approximate 10-fold difference detected in HSV 
thymidine kinase activity (Table 10). 
Expression of the BS2/tk transgene in the preputial gland. 
The expression of the BS2 gene in the preputial gland may be 
expected from the results of the work on the BS6/tk transgene. 
However, a level of HSVTK which was significantly different from 
background levels was only detected in the preputial gland of mouse 
BST D (Table 8). Thus it is difficult to conclude whether the 
transgene produces a very low basal level of expression in this 
tissue or none at all. With data for only one mouse, the expression 
observed for mouse BST D could be a position effect. 
The patterns of expression in the liver, preputial gland and 
testis are line specific. 
The level of expression and pattern of expression of a particular 
gene varies from one founder animal to another for example the 
expression of the BS2/tk transgene in the brain of mouse BST D. 
Line-specific effects are assumed to be due to the uniqueness of 
individual chromosomal integration events. Chromosomal position may 
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influence the accessibility of the genes to transcription factors. 
The quantitative analysis of transgene expression is complicated 
because multiple copies of the genes are usually integrated in a 
tandem array, and there is no means of determining how many of these 
genes are functional templates for transcription. The poor 
correlation between gene copy number and expression (Swift et al., 
1984; Chada et al., 1985) suggests that only a few of the genes 
are expressed or that the entire array is sensitive to chromosomal 
position (Palmiter & Brinster, 1986). 
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DISCUSSION. 
A 2.2 kb group 2 Mup gene promoter region and CAP site directs the 
transcription of the HSVtk reporter gene to the liver and the 
testis of transgenic mice. This observation is important because no 
endogenous BS2 specific gene transcripts have ever been observed 
(see Chapter 1; Shahan et al., 1987b). The expression of the 
BS2/tk transgene in the liver enables one to classify the group 2 
gene BS2 as a hepatic type gene. 
The BS2 promoter contains no obvious structural deficiencies that 
would prevent the initiation of an mRNA at the probable CAP site, 
although several sequence anomalies exist which may contribute to 
transcriptional efficiency (Chapter 5). However, tk specific 
transcripts do not initiate from the BS2 CAP site when a BS2/tk 
construct is transfected into BHKtk fibroblasts, even in the 
presence of the SV40 enhancer. Expression of tk results from the 
productive rearrangement and integration of the plasmid adjacent to 
an active cellular promoter (Chapter 10). In contrast, an identical 
plasmid carrying the BS6 Mup sequences expresses tk from the BS6 
CAP site (Chapter 9). The fact that expression in the liver is 
observed in 4 different transgenic mice or lines rules out the 
possibility that tk expression in this tissue has resulted from a 
"promoter trap " situation. 
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There are several reasons why the BS2 promoter should initiate 
transcription in mouse cells but not in BHK fibroblasts. 
The tissue culture evidence alone could suggest that the promotional 
strength of the BS2 promoter is insufficient to produce enough TK to 
broach the required threshold level for survival of a cell under HAT 
selection. Alternatively, BHK cells may lack tissue specific factors 
which are absolutely essential for expression from the BS2 CAP site 
for example enhancer binding factors. These factors would not be 
essential in the case of BS6 because of the intrinsic strength of 
its promoter. Other possibilities are: 1) that a mutation may have 
disrupted a regulatory protein binding site resulting in the lack of 
binding of a regulatory protein and a consequent lack of 
transcriptional initiation from the BS2 CAP site, or 2) that an 
enhancer in the BS2 sequence is defective. 
The appropriate expression of the BS2/tk hybrid gene in transgenic 
mice rules out the last two possible explanations. 
Why are no endogenous BS2 transcripts observed if the BS2 
promoter is functional? 
If, as seems apparent from the transgenic study, the BS2 promoter 
initiates accurate transcription in mouse cells, the question still 
arises as to why endogenous BS2 transcripts are never observed by 
oligo specific hybridisation (Shahan et al., 1987b; McIntosh & 
Bishop, 1989). This may be because of the intrinsic instability of 
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the BS2 XnRNA. Analysis of the BS2 coding region shows that the RNA 
sequence contains several lesions which render it untranslatable. 
Other acquired sequence mutations may cause mPNA destabilisation 
(see Chapter 5; Clark et al., 1985b). If the Mup BS2 coding 
region can be replaced by a sequence that codes for a stable RNA 
which can be analysed on Northern blots, and a protein translated 
from this RNA which can be evaluated in biochemical assays for 
example HSV thymidine kinase, then the fidelity and tissue 
specificity of the BS2 promoter can be truely evaluated in 
trarisgenic mice. An alternative hypothesis is that the BS2 promoter 
is potentially functional, complete with tissue-specific regulatory 
elements, but is normally silenced as a consequence of its 
chromosomal position. This restraint is absent from the transgene. 
Interestingly, this type of "silencing" phenomenon has been 
demonstrated for other Mup genes (Shi et al., 1989). They 
describe a Mup subfamily (Mup-1.5) containing two genes, Mup-
1.5a and Mup-1.5b, that are nearly identical, differing at only 
three positions over the 4 kb transcription unit and 1 kb of 
flanking DNA. The similarity between these two genes extends over 
about 35 kb. Despite this extensive sequence homology (99.9%) only 
the 5a gene is expressed in BALB/c mice, primarily in the 
submaxillary gland, as shown by using specific oligonucleotide 
probes. However, when a 9.4 kb DNA fragment containing the 5b gene 
was introduced into the mouse germ line, mice in two of four 
transgenic lines expressed the gene at a high level and with the 
tissue specific characteristics of the 5a gene. These results 
suggest that the inactivity of the endogenous Mup-1.5b gene is 
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due to long range inhibitory position effects. 
The BS2 gene is associated with the actively expressed BS6 gene in a 
45 kb palindrome (Clarke et al., 1984b; Bishop, 1985). It is 
possible that the BS6 sequences in the vicinity of the BS2 gene 
confer on it a chromatin configuration which is incompatible with 
transcription. 
Silent genes. 
Silent genes of this type may be a general phenomenon. In the human 
ct-globin gene complex, the functional F--gene is linked to a 
pseudogene which carries one identifiable anther mutation (Hill et 
al., 1985). In some individuals the anther mutation is corrected by 
interchromosomal gene conversion. The corrected gene is not 
expressed in vivo but can be transcribed when introduced into HeLa 
cells or Xenopus oocytes (da Costa Scares et al., 1987). 
Similarly, in the human growth hormone gene (hGH) family, there is a 
difference between the hGH-5-encoding gene and the cDNA sequence. 
The hGH-5 gene can be expressed in vitro but there is no evidence 
that it is expressed in vivo (Seeburg, 1982). However, neither of 
these genes has been shown to be expressed properly when moved to a 
new chromosomal environment, and thus the possibility remains that 
they are inactive due to a defect in a regulatory element, for 




Regardless of the criteria which prevent the endogenous expression 
of the BS2 gene, these experiments show that the BS2 promoter is 
very weak in comparison to the BS6 promoter. This is shown by the 
reduced expression of tk from the BS2 promoter in the liver. The 
similarities in the levels of expression of tk in the testes of 
transgenic mice lines 58 and BST C suggest that the intrinsic 
strength of the BS2 promoter is not important in determining the 
pattern of expression in this tissue. 
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Abbreviations used in the text. 
A adenine 
AMV avian myeloblastosis virus 
aprt adenosyiphosphoribosyltrans ferase 
ATP adenosine 5' triphosphate 
bp base pair 
BHK baby hamster kidney cells 
BSA Bovine serum albumin 
Budr 5-bromodeoxyuridine 
C cytidine 
CTF cellular transcription factor 
cDNA DNA copy of RNA 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
DMEN Dulbecco's modified Eagles medium 
DNA deoxyribonucleic acid 
DTT dithiothreotol 
EDTA diaminoethanetetra-acetic acid 
G guanine 
GRE glucocorticoid responsive element 
HAT Hypoxanthine, aminopterin, thymidine. 
HSV Herpes simplex virus 
kb kilobase 
LTR long terminal repeat 
MMTV mouse mammary tumour virus 
mPNA messenger RNA 
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MUP mouse urinary protein 
Mup mouse urinary protein gene 
neo neomycin gene 
NFl nuclear factor 1 
PIPES Piperazine-N,N'-bis[2-ethanesulfonic acid] 
PPO 2, 5-diphenyloxazole 
POPOP 1 ,4-bis-2-(4-methyl-5-phenyloxazolyl)-benzine 
poly (A) RNA polyadenylated RNA 
RNA ribonucleic acid 
Si single strand specific nuclease 
SDS sodium dodecyl sulphate 
Spi specific transcription factor 1 
SV40 simian virus 40 
T thymidine 
tic thymidine kinase (gene) 
TK thymidine kinase (enzyme) 
TCA tris- [hydroxymethyl] -aminomethane 
TMP thymidine monophosphate 
TTP thymidine triphosphate 
U uridine 
UAE upstream activator element 
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